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염생식  Corydalis heterocarpa  Vitex rotundifolia 부   
생리 질  분리  구조결  
 
  아 
 
국해양  원 해양생명 경 과 
 
 요 약 
 
해양생 자원  요 에  인식이 높아짐에 라 해양생  이용  
새 운 생리 질  개 에 심이 증가 고 있 며, 그 에 도 해  
민 이 이는 독특  경에 식 며 이에 합  작  시킨 
염생식 이 새 운 신 질 자원  주목 고 있다.  
염생식  일종인 염주 불주 니 (Corydalis heterocarpa)  나  
(Vitex rotundifolia)는 국  각처 닷가 모래 사장에  자생 는 노란   
자  이 는 식 써, 조간 에  매우 요  생태  치를 차지 고 
있다. 또  염주 불주 니는 민간에  랫동안 산모  진통이나 경  
치료  사용 었 며, 나 는 에  그 열매를 만 자라 여 
통, 안질, 귓병과 같  질병  치료에 사용 어 다. 염주 불주 니  
경우, 같  속  다른 식 에  다양  이차 사산 이 보고   있 나, 
지 지 염주 불주 니 부  이차 사산  분리나 용  생약  
특 이 보고   없다. 나 는 다  연구에 해 flavonoid   
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terpenoid  합 들이 분리   있 며, 이들  생리 효과 또  
보고 었다. 
라  본 연구에 는 염생식  염주 불주 니  나 에  신규  
이차 사 질  분리 고, 분리  합 에  항산  암 질  
생 지  생체 어 질  용  검토 고자 다. 
그 결과, 염주 불주 니 부  9 종  알 진 합  (1-3, 5, 7-11)과 
2 종  신규 합  (4, 6)  분리 여  11 종   합  
분리 며, 또  나 부  지 합  14 종 (12-19, 21, 22, 27-
30)과 신규 합  5 종 (20, 23-26)  포함 여  19 종  이차 사 질  
분리 다. 분리  합  구조는 분  자료  해 과 헌치  
에 해 결 었 며, 특히, 염주 불주 니  2 종  신규 합 4  
6  각각 (2'S,7'S)-O-(2-methylbutanoyl)-columbianetin 과 (2'S)-columbianetin-3'-
hydrogen sulfate 며, 나  5 종  신규 합  20, 23-26  차  
(5S*,6R*,8R*,9R*,10S*)-6-acetoxy-9-hydroxy-16-hydroxy-13(14)-labden-16,15-
olide, 3α-hydroxy pleuroziol, 9αH-manoyl oxide, abieta-11(12)-ene-9α,13α-
endoperoxide 그리고  abieta-11(12)-ene-9β,13β-endoperoxide  결 었다.  
분리  합  암 포 증식 억  효과를 탐색    연구  
AGS 인체 암 포, HT-29 인체 결장암 포, HT1080 인체 종 포, 
MCF-7 인체 암 포  U-937 인체 구  림 종 포  증식에 미치는 
향  MTT assay 를 통해 찰 다. 그 결과,  다른 암 포에 
여 AGS 인체 암 포에  합  암 포 증식 억  효과가 뛰어나 
apoptosis  이 있는 여러 요소  mRNA  도를 AGS 인체 
암 포에  검토 다.  
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분리  모든 합 에  인체 암 포 증식 억  효과를 검토  결과, 
염주 불주 니  신규 합  6 과 나  합  14 가 가장 이 
뛰어났 며, 이들 합  암 포 증식 억  효과가 pro-/anti-apoptotic 
Bax/Bcl-2 자   조   종양 억  자 p53  p21 자  up-
regulation 에  것  사료 었다.  
합  항산   탐색   일  포내 NO, ROS, GSH  
산  스트 스   iNOS  COX-2 자  mRNA  도를 
macrophage Raw 264.7 포에  인 다.  
포내 NO  함량  Griess reaction  탕  인 며, 포내 
ROS  GSH  생  각각 질인 2',7'-dichlorofluorescin diacetate 
(DCFH-DA)  monobromobimane  이용 여 측 다. 또 , LPS  
자극에 여 산  스트 스가 도  Raw 264.7 포  iNOS  COX-2 
자   RT-PCR 에 여 인 었다. 
산  스트 스가 도  Raw 264.7 포에 염주 불주 니  
나 에  분리  합  농도별  처리  결과, 농도 존  
다  합 이 항산   지님  인 며, 각각  측  법에 
라 합   나타내는 도  차이가 있었다.  특히, 
염주 불주 니에  분리  합  2-4  나 에  분리  합  
16-18  신규 합 23 과 24 가 우  항산   나타내는 것  
인 었다.  
본 연구를 통해 염생식  일종인 염주 불주 니  나  
암 포 증식 억  효과  다양  항산   검색  통해 암   항산  
능  소재 써  개  가능  인   있었다. 특히, 각각  연구에  
 
xviii 
우   보인 합 에  집 인 연구를 통해 새 운 
생리 질  개 이 다. 
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1. Introduction 
1.1. Halophytes (Salt Marsh Plants) 
A marine system with a high variability in physical parameters such as 
temperature, salinity, or radiation can be considered to be an extreme environment. 
Tidal flats, salt marshes, mangrove swamps, and seashore ecosystems are subjected 
to these types of environmental extremes on a daily, seasonal, and annual basis. 
Salt marshes and tidal flats in particular undergo regular and intense changes in 
external parameters such as salinity, due to advancing and receding tidal salt water. 
Organisms that exist in these environments, especially plants that cannot avoid or 
seek shelter from adverse environmental changes, have to acclimatize by 
developing specific stress adaptation responses. In many plant species, this often 
includes the synthesis of unusual secondary metabolites. 
In general, plants are classified as glycophytes or halophytes according to their 
capacity to grow in highly saline environments (Flowers et al., 1977). Halophytes 
naturally occur in ecosystems that have highly saline soils and have developed the 
ability to actively and efficiently exclude salts from their roots and leaves. A 
number of these plants can endure salt concentrations that are more than twice that 
of seawater. Therefore, halophytes can be viewed as salt-resistant plants that are 
well adapted to salinity stress (Min, 1998). 
Halophytes have been classified into coastal salt marsh and estuarine salt marsh 
plants. According to their habitats, coastal salt marshes can be distinguished into 
three types: sandy salt marshes, sandy dune salt marshes, and clayey salt marshes. 
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Two forms of estuarine marshes are recognized: salt swamps and estuarine salt 
marshes (Ministry of Environment, 2006). 
The Ministry of Environment (2006) recently researched fifty-seven plant 
families and 148 halophyte species in coastal and estuarine salt marshes from 59 
sites on the western and the southern coasts of Korea. The distribution of 
halophytes was found to depend on the type of salt marsh. Among the species 
reported, Suaeda maritima, Zoysia sinica, Artemisia fukudo, and Limonium 
tetragonum communities dominated in sandy salt marshes, while Vitex rotundifolia, 
Carex kobomugi, Elymus mollis, and Carex pumila communities dominated in the 
sand dune salt marshes. In the clayey salt marshes, Suaeda japonica, Phragmites 
communis, Carex scabrifolia, and Triglochin maritimum communities were 
predominant. Salt swamps were dominated by Phragmites communis, Triglochin 
maritimum, Suaeda maritima, and Carex scabrifolia communities. In estuarine salt 
marshes, Suaeda japonica, phragmites communis, Aster tripolium, Carex 
scabrifolia, Phacelurus latifolius, and Salicornia herbacea communities 
predominated (Ministry of Environment, 2006). 
These salt marsh plants are recognized environmentally as one of the most 
important ecosystems in tidal zones, since they play vital roles in all aspects of tidal 
ecology, serving as buffers that protect the shorelines from erosion by the force of 
waves and filtering contaminants that leach from the land. In addition, several 
species of halophytes, such as Glehnia littoralis, Salicornia herbacea, and 
Limonium tetragonum, are eaten as human food and are also important components 
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of Korean folk medicines (Masuda et al., 1998; Bang et al., 2002; Kong et al., 
2008). 
These salt marsh plants therefore have attracted the attention of researchers who 
are interested in their capacity to produce unusual bioactive secondary metabolites. 
However, the characterization and biological activities of these secondary 
metabolites have not as yet been fully elucidated (Jo et al., 2002; Bang et al., 2002; 
Han et al., 2003; Lee et al., 2004; Seo et al., 2005; Kong et al., 2008). The aim of 
the present study is to further the characterization and biological investigation of 
secondary metabolites from salt marsh plants. 
 
1.2. Halophytes Corydalis heterocarpa and Vitex rotundifolia 
In the search for novel bioactive secondary metabolites from salt marsh plants, a 
number of halophytes were collected in western Korea and screened for a series of 
biological activities. Among the collected halophytes, extracts from Corydalis 
heterocarpa and Vitex rotundifolia, salt-tolerant plants growing on sandy beaches, 
dunes, and rocky shorelines, showed significant cytotoxicities in a prescreening test 
that used a preliminary MTT assay (Table 1). 
C. heterocarpa is found throughout Korea and Japan. It is a biennial herb that 
bears spikes of yellow flowers. The lanceolate leaves show an alternate phyllotaxis. 
The bead-like fruits ripen in July and contain black seeds lined with a projection. 
Flowering occurs in April-May singly at the ends of the branches. The plant grows 
40-60 cm tall and stands upright and straight with the ridgeline. It has been 
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traditionally used as a folk medicine to treat a variety of symptoms including 
travails and spasms (Lee, 2002). Corydalis species have been extensively 
investigated and have yielded alkaloids, isoquinoline alkaloids, and cyanidin 
glycosides as some of their secondary metabolites (Ma et al., 1999; Tatsuzawa et 
al., 2005; Choi et al., 2007).   
A number of Corydalis constituents have interesting biological activities. For 
example, the alkaloids from Corydalis incise and Corydalis ambigua showed 
antifungal activity against the growth of Cladosporium herbarum (Ma et al., 1999). 
The isoquinoline alkaloids from Corydalis incisa exhibited cytotoxicity against 
human A549, SK-OV-3, SK-MEL-2, and HCT15 tumor cells (Choi et al., 2007). 
Although many secondary metabolites of the genus Corydalis have been reported 
to date, full identification of the secondary metabolites of C. heterocarpa and their 
bioactivity have not yet been reported.  
V. rotundifolia is distributed along the sandy beaches of Korea, China and Japan. 
It is a sprawling shrub, growing 20-80 cm in height, with gray-green to silvery 
round leaves that have a spicy fragrance. The bluish-purple flowers emerge in 
June-September as small clusters at the end of the branch. The round fruit are about 
6mm in diameter and are bluish purple or black when ripe in September-October. 
The seeds and fruits of V. rotundifolia are used for treatment of various allergic 
diseases as well as for colds, headache, migraines, and eye pain (Lee, 2002). 
Several natural products, such as flavonoids, diterpenoids, and sesqiterpenoids 
have previously been reported in V. rotundifolia extracts (Kondo et al., 1986; Ono 
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et al., 1997; You et al., 1998; Ono et al., 1998; Kawazoe et al., 1999; Ono et al., 
1999; Ono et al., 2000; Shin et al., 2000; Ko et al., 2000; Ko et al., 2001; Ono et 
al.a,b, 2001; Wang et al., 2005).  
All known secondary metabolites (V1 - V57) isolated from V. rotundifolia are 
illustrated in Fig. 1. Among these, flavonoids such as vitexicarpin and artemetin, 
and diterpenes such as rotundifuran and ferruginol, have shown antiproliferative 
and antioxidant effects in vitro (Ono et al., 1999; Ko et al., 2000; Ko et al., 2000; 
Wang et al., 2005). Therefore, these compounds present in V. rotundifolia might 
serve as potent preventative agents against chronic illnesses such as diabetes, heart 
disease, and cancer. 
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Rosa rugosa - ++ 
Messerschmidia sibirica - ++ 
Lathyrus japonicus - - 
Carex scabrifolia - ++ 
Sonchus brachyotus - ++ 
Salsola komarvii lljin - + 
Suaeda asparagoides - - 
Suaeda japonica - - 
Erigron annuus - +++ 
Ixeris tamagawaensis - - 
Imperata cylindrica - - 
Aster tripolium - ++ 
Calystegia soldanella - + 
Glehnia littoralis - ++ 
Artemisia capillaris - ++ 
Tetragonia tetragonoides - +++ 
Vitex rotundifolia ++ +++ 
Corydalis heterocarpa ++ +++ 
Aster spathulifolius - - 
Salicornia herbacea - ++ 
Carex kobomugi - +++ 
Polygonum bellardi - + 
Species MeOH extracts + CH2Cl2 extracts (Inhibition %) 
Hypochoeris radicata ++ 
Erigron annuus - 
Suaeda maritima - 
+++: inhibition value > 90%, ++: 70% < inhibition value ≤ 90%, +: 50% < inhibition 
value ≤ 70%, -: inhibition value ≤ 50%. Final concentration of extracts were 100 
μg/mL 
 






















V1  rotundifuran V2  prefotundifuran V3  vitexilactone V4  previtexilactone
V5. R1, R4, R5 = OH,  R2, R3 = H  
      (luteolin)
V6. R1 - R3, R5 = OMe,  R4 = OH  
      (vitexicarpin)
V7. R1 - R3 = OMe, R4 - R5 = OH   
      (2',3',5-trihydroxy-3,6,7-trimethoxyflavone)
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V10  vanillic acid
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Figure 1. Natural products isolated from Vitex rotundifolia. 
 








V19  R=H  (vitrofolal A)
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Ono et al., 1998; Ono et al.,1999; Ono et al.b, 2001
 
 
Figure 1. (continued) 
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Figure 1. (continued) 
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Figure 1. (continued) 
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1.3. Oxidative/Nitrosative Stress 
Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are highly 
reactive molecules or molecular fragments that contain one or more unpaired 
oxygen/nitrogen atoms (Nordberg and Arnér, 2001; Pauly et al., 2006). It is well 
known that ROS/RNS include not only the free radicals such as superoxide anion 
(O2
-
•), hydroperoxyl radical (HO2•), hydroxyl radical (HO•), peroxyl radical (ROO•), 
alkoxyl radical (RO•), nitric oxide radical (NO•), and nitrogen dioxide radical 
(NO2•), but also include non-radicals as hydrogen peroxide (H2O2) and 
peroxynitrite anion (ONOO-) (Curtin et al., 2002; Gomes et al., 2005; 
Mangialasche et al., 2009) (Fig. 2). 
ROS and RNS are continuously generated under normal conditions, as a 
consequence of normal aerobic metabolism. They have various physiological roles 
in the human body, but they are removed rapidly from the body for the reason that 
their persistence or over accumulation will cause cell damage and cell death. In 
general, living systems have developed defense mechanisms against the harmful 
effects of ROS/RNS. For example, a variety of antioxidant defense systems, such 
as enzyme and non-enzyme antioxidants, help to prevent and repair ROS/RNS 
induced damage. Thus, the balance between the formation of ROS/RNS and 
antioxidant defenses is maintained in the body (Nordberg and Arnér, 2001; Gomes 
et al., 2005). However, imbalances in biological systems occur when excessive 
production of ROS/RNS overwhelms the antioxidant defense system or when there 
is a significant decrease or lack of antioxidant defenses. The uncontrolled 
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ROS/RNS levels then initiate a series of harmful biochemical events that are 
associated with diverse pathological processes. The damage induced by 
overproduction of ROS/RNS is termed oxidative/nitrosative stress and these 
processes can lead to various diseases and characteristic types of cellular damage 
(Nordberg and Arnér, 2001; Gomes et al., 2005; Valko et al., 2007). 
 
 
(Mangialasche et al., 2009) 
Figure 2. The main ROS and RNS responsible for biomolecule damage in the human body, 
and their main sources. The most reactive ROSs are the superoxide anion and the hydroxyl 
radical. Peroxynitrite is the main RNS, but nitrogen dioxide and nitronium ion also exhibit 
significant oxidative properties. Peroxy radicals (ROO-) also occur, with the simplest 
peroxyl radical being HOO-, termed hydroperoxyl radical or perhydroxyl radical. Another 
important peroxyl radical is LOO-, called lipid peroxyl radical. Enzymes such as nitric 
oxide synthases catalyze the formation of reactive nitrogen radicals. 
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1.4. Human Disease and Solution 
As increasing wealth and industrialization has occurred on the planet, cancer has 
rapidly become one of the major unsolved public health problems in the world. 
Cancer still accounts for more deaths than does heart disease in humans, even 
though various treatment strategies have been developed (Jemal et al., 2008). In 
Korea specifically, the rate of cancer death has continuously increased since 1980 
(Lee et al., 1996). The main reasons for the greater cancer burden are the earlier 
smoking, earlier alcohol use, and the adoption of Western nutrition and lifestyle. 
The Western lifestyle is characterized by a highly caloric diet, rich in fat, combined 
with low physical activity, resulting in an overall energy imbalance. It is associated 
with an imbalance of redox systems due to lack of nutrients known as antioxidants. 
The oxidative/nitrosative damage induced by a shortage of these nutrients is 
strongly correlated with diverse pathological processes, including aging, 
cardiovascular diseases, arterial hypertension, diabetes, and cancer. Among these 
diseases, the relationship between oxidative/nitrosative stress and cancer has been 
the subject of much speculation and controversy (Ames et al., 1993; Dröge, 2002; 
Valko et al., 2007; Aslan et al., 2008; Kirschvink et al., 2008; Liu et al., 2008). For 
these reasons, diet is now recognized as an important environmental factor in 
cancer induction and prevention, and much attention has been focused on finding 
chemopreventive or therapeutic agents from natural sources such as fruits, 
vegetables, terrestrial non-crop plants, and marine algae (Park and Pezzuto, 2002; 
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Jung et al., 2004; Lee et al., 2004; Seo et al., 2004; Lee and Seo, 2006; Stan et al., 
2008). 
The mechanisms of action of cancer chemopreventive agents can be classified 
into three types: inhibitors of carcinogen formation, ‘blocking’ (anti-initiating) 
agents, and ‘suppressing’ (anti-promotion/anti-progression) agents, according to 
the in vivo carcinogenesis model (Table 2) (Morse and Stoner, 1993). Among these 
mechanisms, an anti-initiating agent will suppress the mutation of DNA, RNA, or 
proteins by scavenging reactive species (ROS/RNS). Anti-promotion agents block 
the processes by which mutated cells are transformed into cancer cells.  
Cancer is associated with decreased apoptosis and the development of apoptosis 
resistance in cancer cells is now viewed as a significant contributing factor to the 
failure of cancer therapies (Watson, 2004). Thus, the mechanisms of action of 
chemopreventive agents from natural products might be related to the modulation 
of relevant proteins or signal transduction cascades involved in the carcinogenesis 
process.  
In the past, biomarkers have been used successfully as prognostic or diagnostic 
indicators for chemoprevention studies, and a number of these intermediate 
biomarkers are shown in table 3. Of the rest, mutations in the p53 gene are the most 
frequently observed genetic changes in tumor suppressor genes in human cancers 
(Moll et al., 2005; Garcea et al., 2005; Roos and Kaina, 2006). Expression of p53 
induces a further transcriptional activation of the p21 gene, which inhibits cdk-
mediated retinoblastoma protein phosphorylation, leading cells to arrest in G1 
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(Garcea et al., 2005). In addition, p53 activates expression of Bax (a pro-apoptotic 
gene) and suppresses Bcl-2 (an anti-apoptotic gene), leading to cellular apoptosis. 
Briefly, several genes such as p53, p21, and Bax are believed to regulate cellular 
responses to DNA damage by inducing cell growth arrest or by promoting 
apoptosis in abnormal cells (Moll et al., 2005; Garcea et al., 2005; Roos and Kaina, 
2006; Valko et al., 2007) (Fig. 3). Therefore, apoptosis-related factors (apoptotic 
index, Bcl-2, Bax, etc.), cell proliferation/cycle-related factors (p53, p21, etc.), and 
other factors are analyzed as part of the investigation presented in this thesis. 
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Table 2. Mechanisms of action of cancer chemopreventive agents 
 Mechanism  Examples 
blocking  
(anti-initiating) 
Inhibition of cytochrome P450 dithiocarbamates 
isothiocyanates 
 Induction of cytochrome P450 indole-3-carbinol 
β-naphthoflavone 
 Induction of phase Ⅱ enzymes isothiocyanates 
polyphenols 
 Scavenging electrophiles ellagic acid 
N-acetylcysteine 
sodium thiosulfate 













 Protease inhibition tosyl phenylalanine 
antipain 
 Induction of differentiation retinoids 
calcium 
vitamin D 
 Inhibition of oncogene expression lovastatin 
limonene 
antisense 
 Inhibition of protein kinase C staurosporine 
threo-
dihydrosphingosine 
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Table 3. Intermediate biomarkers 
Class Examples 
Genomic biomarkers oncogene activation 
tumor suppressor gene inactivation 
altered DNA methylation 
abnormal DNA content 
carcinogen-DNA adducts 
Markers of proliferation proliferating cell nuclear antigen 




Markers of differentiation blood group antigens 
growth factors 




colonic adenomatous polyps 
dysplastic nevi 
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1.5. Aims of the Research  
The overall aim of this study was to pursue new bioactive secondary metabolites 
from halophytes collected in Korea, using a bioactivity-guided separation.  
On the basis of a preliminary bioactivity screening test toward 25 species of 
halophytes, two halophytes, C. heterocarpa and V. rotundifolia, were ultimately 
selected for further scrutinizing of their secondary metabolite compositions (Table 
1).   
Halophytes were extracted and the crude extracts were separated on the basis of 
their chemical polarity and bioactivities, using a diverse array of chromatographic 
methods (C18 and silica gel column chromatography, preparative TLC, HPLC, etc.). 
Chemical structures of the isolated pure compounds were determined from the 
structure elucidation of pure compounds with the aid of MS, IR and NMR spectra, 
and their antiproliferative and antioxidant effects have been also evaluated. 
The antiproliferative effects of pure compounds obtained from C. heterocarpa 
and V. rotundifolia were investigated using a MTT assay and mRNA expression of 
several factors (Bax, Bcl-2, p53, p21) related to apoptosis in human cancer cell 
lines. The antioxidant effects of the compounds were examined by measuring 
intracellular ROS (reactive oxygen species), NO (nitric oxide), GSH (glutathione). 
In addition, mRNA expression of iNOS, pro-oxidant and COX-2 in Raw 264.7 
cells in the presence of the isolated secondary metabolites was evaluated by a RT-
PCR method. 
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2. Materials and Methods 
2.1. Plant Material 
Whole plants of Corydalis heterocarpa and Vitex rotundifolia were collected in 
Muan-gun, Jeollanamdo, Korea in July, 2003 (Fig. 4). The plants were identified 
by Seong Gi Mun from their morphological characters. Voucher specimens are 
deposited in the laboratory of Jeom-Sook Lee (voucher No. 03H-7 and 03H-6, 




(a) Corydalis heterocarpa (b) Vitex rotundifolia 
Figure 4. Photographs of salt marsh plants (a) Corydalis heterocarpa and (b) Vitex 
rotundifolia. 
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2.2. General Experimental Procedures 
Optical rotations were determined on a Perkin-Elmer polarimeter 341. NMR 
spectra were recorded in CD3OD and CDCl3 on a Varian Mercury 300 
instrument at 300 MHz for 1H and 75 MHz for 13C using standard pulse sequence 
programs. All chemical shifts were recorded with respect to TMS as an internal 
standard. Mass spectroscopic data were obtained at the Korean Basic Science 
Institute, Seoul, Korea. Column chromatography was carried out on RP 18 (YMC-
Pack ODS-A, 12nm, S-5 μm, 250×10mmI.D., YMC, USA) and silica gel (YMC-
Pack SIL, 12nm, S-5 μm, 250×10mmI.D., YMC, USA). TLC plate (PLC Silica gel 
60 F254, 0.5mm, 20×20cm Merck, Germany) were used for TLC analysis. High 
performance liquid chromatography (HPLC) was performed on a Dionex P580 
HPLC system equipped with a Varian 350 RI detector. All solvents used were 
spectral grade or were distilled from glass prior to use.  
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2.3. Extraction and Isolation of Corydalis heterocarpa 
2.3.1. Extraction and Fractionation 
The collected C. heterocarpa were air-dried and chopped into small pieces. The 
chopped plants were extracted with CH2Cl2 (3 L x 2) at room temperature for 2 
days and filtered (No. 2, whatman). The residue was re-extracted with MeOH (3 L 
x 2) at room temperature for 2 days. The two extracts were combined, evaporated 
under reduced pressure (EYELA, N-N series, Japan), and the crude extracts (41.1 
g) were partitioned between CH2Cl2 and water. The organic layer was further 
partitioned between n-hexane and 85% aq. MeOH, and the aqueous layer was 
partitioned with n-BuOH and H2O, successively, to afford the n-hexane (7.3 g), 
85% aq. MeOH (12.0 g), n-BuOH (4.3 g), and water (17.0 g) (Scheme 1).  
 
2.3.2. Isolation of Compounds 
A portion of the 85% aq. MeOH fraction (7.0 g) was subjected to C18 reversed-
phase vacuum flash chromatography using stepwise gradient mixtures of MeOH 
and water (50, 60, 70, 80, 90% aq. MeOH, and 100% MeOH) as eluents to give 6 
subfractions (Fr. 1 – Fr. 6). Fr. 1 was separated by preparative TLC on a silica gel 
with the solvent system 10% MeOH in CH2Cl2 to yield 1 (329.1 mg). Reversed-
phase HPLC (ODS-A, 65% aq. MeOH) of Fr. 3 and further purification using 
reversed-phase HPLC (ODS-A, 67% / 50% aq. CH3CN) gave 2 (14.9 mg), 7 (13.6 
mg), and 11 (6.4 mg). 3 (63.8 mg) and 4 (146.9 mg) were obtained from Fr. 4 by 
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using reversed-phase HPLC (ODS-A, 75% aq. MeOH) followed by preparative 
TLC (silica, 100% CH2Cl2) (Scheme 2).  
Half of the n-BuOH fraction (2.2 g) was chromatographed on C18 reversed-phase 
vacuum flash column by stepwise gradient elution of a mixture of MeOH and water 
(50, 60, 70, 80, 90% aq. MeOH, and 100% MeOH) to give 6 subfractions (Fr. 1 – 
Fr. 6). Fr. 1 was further separated on a silica gel column with stepwise gradient 
mixture (0, 5, 10, 20, 30, 40, 50, 70, and 100% MeOH in CHCl3) to give 9 
subfractions (Fr. 1-1 – Fr. 1-9). 5 (4.7 mg) was isolated from Fr. 1-3 by using 
reversed-phase HPLC (ODS-A, 45% aq. MeOH) followed by preparative TLC 
(silica, EtOAc : MeOH : H2O (30 : 5 : 4)). Fr. 1-4 was separated by preparative 
TLC on a silica gel with EtOAc : MeOH : H2O (23 : 4 : 3) to afford 8 (6.9 mg) and 
three mixtures (Mix. 2 – Mix. 4). Each mixture was analyzed with reversed-phase 
HPLC (ODS-A, 30 / 43 / 60% aq. MeOH) to yield 6 (5.7 mg), 9 (6.8 mg), and 10 
(4.5 mg) (Scheme 3). 
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RP 18 column with gradient mixtures
(A portion of 85% aq. MeOH fraction; 7.0g)
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Scheme 2. Isolation procedure of compounds (1-4, 7, 11) from Corydalis heterocarpa. 
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Scheme 3. Isolation procedure of compounds (5-6, 8-10) from Corydalis heterocarpa. 
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2.3.3 Alkaline Hydrolysis of Compound 4 
A solution of 4 (5 mg) in MeOH (2 mL) was added 2 mL of 1.0 M KOH solution. 
The mixture was stirred overnight at room temperature and then evaporated to 
dryness. The residue was partitioned between EtOAc and water. After removal of 
solvent from the organic layer, (2'S)-columbianetin (1, 2.5 mg) was obtained 
(Scheme 4). 
 
2.3.4. Synthesis of Compound 4 
(S)-(+)-2-methylbuanoic acid (0.51 g) in SOCl2 (1 mL) was stirred under reflux 
for 1 h. The reaction mixture was concentrated under reduced pressure to give (S)-
(+)-2-methylbutanoyl chloride. A solution of 9.7 mg of 1 in CH2Cl2 (2 mL) was 
added to a mixture of (S)-(+)-2-methylbutanoyl chloride and excessive 4-N,N-
dimethylaminopyridine (50 mg) in CH2Cl2 (2 mL). After stirring overnight at room 
temperature, the crude ester was purified by silica gel thin layer chromatography 
with CH2Cl2 solvent system followed by reversed-phase HPLC (YMC-Pack ODS-
A, 75% aq. MeOH) to afford the (2'S,7'S)-O-2-methylbutyryl-columbianetin (6.6 
mg) (Scheme 5).  
 
2.3.5. Acid Hydrolysis of Compound 6 
A solution of 6 (2 mg) in 0.05 N HCl (5 mL) was heated at 95 oC for 1.5 h. After 
hydrolysis the solution was extracted with EtOAc to give (2'S)-comlumbianetin (1). 
Sulfate ion (SO4
2-) was detected from the concentrated aqueous layer (Scheme 6). 
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Scheme 4. Alkaline hydrolysis of compound 4 isolated from Corydalis heterocarpa. 
 
 
Scheme 5. Synthesize of compound 4 by esterification of compound 1 isolated from 
Corydalis heterocarpa with (S)-(+)-2-methylbutanoic acid. 
 
 
Scheme 6. Acid hydrolysis of compound 6 isolated from Corydalis heterocarpa. 
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2.4. Extraction and Isolation of Vitex rotundifolia 
2.4.1. Extraction and Fractionation 
The air-dried samples of V. rotundifolia were cut into small pieces and the pieces 
extracted for 2 days with MeOH (3 L x 2) and CH2Cl2 (3 L x 2), in turn. The two 
combined crude extracts (145.3 g) were filtered and concentrated under vacuum 
and partitioned between CH2Cl2 and water. Later, the organic layer was further 
partitioned between n-hexane (33.6 g) and 85% aq. MeOH (21.0 g), and the 
aqueous layer was fractionated with n-BuOH (39.0 g) and H2O (47.8 g), 
successively (Scheme 7).  
 
2.4.2. Isolation of Compounds 
A portion of n-BuOH fraction (15.0 g) and 85% aq. MeOH fraction (21.0g) were 
subjected to C18 reversed-phase vacuum flash chromatography using stepwise 
gradient mixtures of MeOH and water (50, 60, 70, 80, 90% aq. MeOH, and 100% 
MeOH) as eluents to give 6 subfractions (Fr. 1 – Fr. 6), respectively. Fr. 3 obtained 
after C18 flash chromatography of n-BuOH fraction was purified by reversed-phase 
HPLC (ODS-A, 67% aq. MeOH) to give 12 (119.2 mg) (Scheme 8). Fr. 4 obtained 
from 85% aq. MeOH fraction was separated by reversed-phase HPLC (ODS-A, 
78% aq. MeOH) to give 14 (71.4 mg) and six mixtures (Mix. 1 – Mix. 6), in order 
of elution. Mix. 1 / 2 / 3 were separately purified by reversed-phase HPLC with 
same solvent (ODS-A, 50% aq. CH3CN) to give 13 (2.5 mg) and 22 (4.9 mg) / 20 
(2.5 mg) and 23 (20.4 mg) / 15 (24.8 mg) and 16 (15.0 mg), respectively. Mix. 4 / 5 
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/ 6 was separated by reversed-phase HPLC (ODS-A, 63 / 68 / 60% aq. CH3CN) to 
afford 19 (18.0 mg) / 17 (55.7 mg) / 18 (69.9 mg), respectively. 21 (2.9 mg) was 
isolated from Mix. 5 by using normal-phase HPLC (SIL, 25% EtOAc in hexane) 
followed by reversed-phase HPLC (ODS-A, 60% aq. CH3CN) (Scheme 8).  
A portion of the n-hexane (10 g) fraction was separated on a silica gel column 
chromatography with stepwise gradient mixtures of EtOAc and n-hexane (0, 10, 20, 
30, 40, 50, 60, 70, and 100% EtOAc in hexane) as eluents to give 9 subfractions (Fr. 
1 – Fr. 9). Fr. 2 was separated further by silica gel column chromatography with 0, 
2, 4, 4, 6, 6, 8, and 10% EtOAc in hexane (Fr. 2-1 – Fr. 2-8). Fr. 2-3 was further 
purified by normal-phase HPLC (SIL, 100% hexane) to yield 24 (18.9 mg), 25 
(31.4 mg), and 26 (30.8 mg). 29 (4.2 mg) and 30 (7.0 mg) were isolated from Fr. 2-
3 by using reversed-phase HPLC (ODS-A, 90% CH3CN in dioxane) followed by 
normal-phase HPLC (SIL, 100% hexane). Reversed-phase HPLC (ODS-A, 75% 
THF) of Fr. 2-4 afforded 28 (4.2 mg), and further purification of Fr. 2-4 using 
HPLC (SIL, 3% EtOAc in hexane, and ODS-A, 85% aq. CH3CN, in turn) gave 27 
(11.0 mg) (Scheme 9). 
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Scheme 8. Isolation procedure of the compounds (12-23) from Vitex rotundifolia.  
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Scheme 9. Isolation procedure of the compounds (24-30) from Vitex rotundifolia.  
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2.5. Antiproliferative Effects 
2.5.1. Cell Culture and Inhibition of Cancer Cell Proliferation 
AGS (human gastric cancer), HT-29 (human colon cancer), HT-1080 (human 
fibrosarcoma), MCF-7 (human breast cancer) and U-937 (human leukemia) cell lines were 
separately grown as monolayers in T-75 tissue culture flasks (Nunc, Roskilde, Denmark) 
at 5% CO2 and 37 ºC humidified atmosphere using appropriate media supplemented with 
10% fetal bovine serum (FBS), 2 mM glutamine and 100 μg/mL penicillin-streptomycin. 
Dulbecco’s modified eagle medium (DMEM, Gibco-BRL, Gaithersburg, MD, USA) and 
RPMI 1640 (Gibco-BRL, Gaithersburg, MD, USA) were used as the culture mediums and 
the medium was changed twice or three times each week. The antiproliferative effects of 
the isolated compounds on cultured cells were measured using MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay, which is based on the 
conversion of MTT to MTT-formazan by mitochondrial enzyme (Hansen et al., 1989). 
The cells were grown in 96-well plates at a density of 5 × 104 cells/well. After 24 h, cells 
were washed with fresh medium and treated with different concentrations of samples. 
After incubation for 24 h, the cells were rewashed and incubated with 100 μL of MTT (1 
mg/mL) for 4 h. Finally, 150 μL of DMSO was added to solubilize the formed formazan 
crystals. The amount of formazan crystal was determined by measuring the absorbance at 
540 nm using a multidetection microplate fluorescence spectrophotometer synergy HT 
(Bio-Tek instruments Inc., Winooski, VT, USA). Relative cell viability was determined by 
the amount of MTT converted into a formazan. Viability of cells was quantified as a 
percentage compared to the control. 
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2.5.2. Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
Total RNA was isolated using a Trizol reagent (Invitrogen Co., CA, USA) 
following the manufacturer’s recommendations. Total RNA was digested with 
RNase-free DNase (Roche, Penzberg, Germany) for 15 min at 37 ºC and repurified 
by the RNeasy kit according to the manufacturer’s protocol (Promega, Madison, 
WI). The target cDNA was synthesized from 2 μg total RNA by incubation at 37 
ºC for 1 h with AMV reverse transcriptase (Amersham) with random 
hexanucleotide according to the manufacturer’s instructions.  
Primers to specifically amplify the genes interested were as follows; forward 5'-
CAG-CTG-CAC-CTG-ACG-3' and reverse 5'-GCT-GGG-TAG-GTG-CAT-3' for 
Bcl-2 gene; forward 5'-ATG-GAC-GGG-TCC-GGG-GAG-3' and reverse 5'-TGG-
AAG-AAG-ATG-GGC-TGA-3' for Bax gene; forward 5'-GCT-CTG-ACT-GTA-
CCA-CCA-TCC-3' and reverse 5'-CTC-TCG-GAA-CAT-CTC-GAA-GCG-3' for 
p53 gene; forward 5'-CTC-AGA-GGA-GGC-GCC-ATG-3' and reverse 5'-GGG-
CGG-ATT-AGG-GCT-TCC-3' for p21 gene. For the internal control gene GAPDH, 
forward 5'-CGG-AGT-CAA-CGG-ATT-TGG-TCG-TAT-3' and reverse 5'-AGC-
CTT-CTC-CAT-GGT-GGT-GAA-GAC-3' were used.  
Amplification was performed in a master-cycler (Eppendorf, Hamburg, 
Germany) with cycles of denaturation at 94 ºC for 30 s, annealing at 58 ºC for 30 s, 
and extension at 72 ºC for 30 s, respectively. The amplified PCR products were run 
in 1.0% agarose gels and visualized by ethidium bromide (EtBr). 
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2.6. Antioxidant Effects 
2.6.1. Cell Culture and Cytotoxicity Determination using MTT assay  
Raw 264.7 macrophage cells were cultured in Dulbecco’s modified eagle 
medium (DMEM, Gibco-BRL, Gaithersburg, MD, USA) containing 10% fetal 
bovine serum (FBS), 2 mM glutamine and 100 μg/mL penicillin-streptomycin 
(Gibco-BRL, Gaithersburg, MD, USA) and maintained at 37 ºC in humidified 
incubator containing 5% CO2. The cell number was adjusted to 5×10
4 cells/well in 
96-well plates. After cells were cultured in the presence of sample or not for 24 h, 
cell viability was determined by colorimetric measurement of the reduction product 
of MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide], which is 
based on the conversion of MTT to MTT-formazan by mitochondrial enzyme 
(Hansen et al., 1989). Briefly, the original medium was washed with fresh medium, 
then, 100 μL of MTT solution (1 mg/mL) was added to each well. After 4 h, 150 
μL of DMSO was added to solubilize the formed formazan crystals, and the 
amount of formazan crystal was determined by measuring the absorbance at 540 
nm using a multidetection microplate fluorescence spectrophotometer synergy HT 
(Bio-Tek instruments Inc., Winooski, VT, USA). Relative cell viability was 
determined by the amount of MTT converted into a formazan. Viability of cells 
was quantified as a percentage compared to the control.  
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2.6.2. Determination of Nitric Oxide (NO) Production 
To determine the effects of compounds on the NO production in the cultured 
media, the Raw 264.7 cells were seeded at a density of 5×104 cells/well in 96-well 
plates using DMEM without phenol red. Following incubation for 24 h, the 
adherent cells were washed three times with PBS. The cells were then incubated in 
the medium with sample, with or without 1 μg/mL final concentration of LPS. 
After incubation for 48 h, the production of NO was determined based on the 
Griess reaction (Green et al., 1982). Each of the 50 μL of cultured medium was 
added onto a 96-well microtiter plate. The 50 μL of Griess reagent was added to 
each well and stand for 15 min at room temperature. The absorbance of the mixture 
at 550 nm was measured by using a multidetection microplate fluorescence 
spectrophotometer synergy HT (Bio-Tek instruments, USA). The concentrations of 
nitrite were calculated from regression analysis, using serial dilutions of sodium 
nitrite as a standard.  
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2.6.3. Measurement of Intracellular Reactive Oxygen Species (ROS) Levels 
The extent of intracellular ROS formation was measured by using 2',7'-
dichlorofluorescin diacetate (DCFH-DA) as the substrate (Okimoto et al., 2000). 
Raw 264.7 cells growing in fluorescence microtiter 96-well plates were loaded with 
20 μM DCFH-DA in HBSS for 20 min in the dark. Nonfluorescent DCFH-DA dye, 
which freely penetrates into cells, gets hydrolyzed by intracellular esterases to 2',7'- 
dichlorodihydrofluororescein (DCFH2), and traps inside the cells (Curtin et al., 
2002). After treatment with the different concentrations of sample, the Raw 264.7 
cells were incubated for 1 h. The culture medium was removed, the cells were 
washed three times with PBS, and 500 μM H2O2 dissolved in HBSS was added to 
cells. The formation of 2',7'-dichlorofluorescein (DCF), a fluorescent compound 
(λexcitation=485 nm; λemission =528 nm) due to oxidation of DCFH2 in the presence of 
various ROS, was read after every 30 min using a multidetection microplate 
fluorescence spectrophotometer synergy HT (Bio-Tek instruments, USA). Time-
dependent effects of the compounds were plotted and compared with fluorescence 
intensity of control and blank groups.  
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2.6.4. Measurement of Intracellular Glutathione (GSH) Levels 
Intracellular GSH concentration in intact cells was tested with 
monobromobimane as a thiol-staining reagent (Poot et al., 1986). Briefly, the Raw 
264.7 cells were seeded into fluorescence microtiter 96-well plates at a density of 
5×104 cells/mL and incubated with sample for 1h. The cells were washed three 
times with PBS, and monobromobimane (mBBr) in 1% DMSO was treated to cells 
at a final concentration of 40 μM for 30 min at 37 ºC in the dark. The fluorescence 
intensity was measured (λexcitation=360 nm; λemission=465 nm) after every 30 min 
using a multidetection microplate fluorescence spectrophotometer synergy HT 
(Bio-Tek instruments, USA). The averaged fluorescence values of cell populations 
were plotted and compared with control group. 
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2.6.5. Reverse Transcription-Polymerase Chain Reaction (RT-PCR) 
The levels of iNOS and COX-2 mRNA were determined by RT-PCR. Total 
RNA was isolated with Trizol reagent (Invitrogen Co., CA, USA) according to 
manufacturer’s recommendations. cDNA was synthesized from 2 μg total RNA by 
incubation at 37 ºC for 1 h with AMV reverse transcriptase (Amersham) with 
random hexanucleotide. The expression of a housekeeping gene, GAPDH, was 
used as an internal control. 
Primers to specifically amplify the genes interested were as follows; forward 5'-
AGA-GAG-ATC-CGG-TTC-ACA-3' and reverse 5'-CAC-AGA-ACT-GAG-GGT-
ACA-3' for iNOS gene; forward 5'-TTC-AAA-TGA-GAT-TGT-GGG-AAA-ATT-
GCT-3' and reverse 5'-AGA-TCA-TCT-CTG-CCT-GAG-TAT-CTT-3' for COX-2 
gene. For the internal control gene GAPDH, forward 5'-CGG-AGT-CAA-CGG-
ATT-TGG-TCG-TAT-3' and reverse 5'-AGC-CTT-CTC-CAT-GGT-GGT-GAA-
GAC-3' were used.  
Amplification was performed in a master-cycler (Eppendorf, Hamburg, 
Germany) with cycles of denaturation at 94 ºC for 30 s, annealing at 54 ºC for 30 s, 
and extension at 72 ºC for 60 s, respectively. The PCR products were visualized by 
electrophoresis through 1.0% agarose gel stained with ethidium bromide (EtBr). 
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2.7. Statistical Analysis 
The data were presented as mean ± SD. Differences between the means of the 
individual groups were assessed by one-way ANOVA with Duncan’s multiple 
range tests. Differences were considered significant at p < 0.05. The statistical 
software package, SAS v9.1 (SAS Institute Inc., NC, USA), was used for these 
analyses.  
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3. Results and Discussion 
3.1. Secondary Metabolites Isolated from Corydalis heterocarpa 
The crude extract of C. heterocarpa was partitioned with CH2Cl2 and H2O. Each 
layer was further partitioned with n-hexane/85% aq. MeOH and n-BuOH/H2O, 
respectively. The n-BuOH and 85% aq. MeOH fractions were then purified by 
various types of column chromatography, TLC, and HPLC using different solvent 
combinations, to yield nine compounds including two new compounds (4 and 6) 
(Fig. 5).  
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Figure 5. Chemical structure of compounds 1-11 isolated from Corydalis heterocarpa. 
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3.1.1. Structural Determination of Compounds 1-3 and 5 
Compound 1 was obtained as an amorphous white solid. The molecular formula 
of 1 was determined to be C14H14O4 by a combination of EIMS and 
13C NMR 
spectrometry. The 1H NMR spectrum of 1 contained signals for two tertiary 
methyls [δ 1.37, 1.24 (3H each, all s)], a methylene [δ 3.31 (2H, dd, J = 9.0, 4.8 
Hz)], an oxygen-substituted methane [δ 4.79 (1H, t, J = 9.0 Hz)], and two sets of 
ortho-coupled aromatic protons [δ 6.20, 7.61 (1H each, all d, J = 9.5 Hz), δ 6.73, 
7.26 (1H each, all d, J = 8.3 Hz)]. The 13C NMR spectrum indicated the presence of 
14 carbons, including one ester carbonyl carbon, two sp2 and two oxygenated sp3 
carbons, one aliphatic carbon, and one phenyl group (Table 4). These data were 
typical furanocoumarin signals and a more detailed chemical structure was 
identified by extensive 2D NMR experiments, such as gDQCOSY, TOCSY, 
NOESY, gHMQC, and gHMBC. These spectral data established 1 to be the 
columbianetin, which has been previously reported in several plants, including 
Peucedanum oreoselinum, Ligusticum seguieri, Cnidium japonicum, Xanthoxylum 
arnottianum, Lomatium dissectum, and Zanthoxylum punctatum (Lemmich et al., 
1970; Lemmich et al., 1971; Hata et al., 1972; Ishii et al., 1974; Van Wagenen et 
al., 1988; Stermitz and Sharifi, 1977). On the basis of comparison with published 
spectral data, the structure of compound 1 was established as (2'S)-columbianetin 
(Willette and Soine, 1964; Lemmich et al., 1970; Shipchandler et al., 1970; 
Lemmich et al., 1971; Steck, 1971; Hata et al., 1972; Bandopadhyay et al., 1974; 
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Ishii et al., 1974; Stermitz and Sharifi, 1977; Mchale et al., 1987; Van Wagenen et 
al., 1988; Awale et al., 2006). 
Compound 2 was obtained as an amorphous white solid with an elemental 
composition of C16H16O5, as determined from its EIMS and 
13C NMR data. The 1H 
and 13C NMR spectra of 2 were very similar to those of 1, except for the acetyl 
groups [δC 170.0, 22.3; δH 1.97 (3H, s)]. Therefore, the structure of compound 2 
was construed to be libanoridin by the analysis of 1D and 2D NMR experiments, as 
well as by comparison with the literature values (Lemmich et al., 1970; Lemmich 
et al., 1971; Hata et al., 1972). 
Compound 3 was also similar to compound 1 and yielded molecular formula 
C18H20O5 by EIMS and 
13C NMR spectral data. The 1H and 13C NMR spectra of 3 
displayed typical features similar to those of 1, except for the methylpropanoyl 
moiety [δC 176.0, 34.9, 19.0, 18.9; δH 2.40 (1H, m), 1.04 (3H, d, J = 7.2 Hz), 1.03 
(3H, d, J = 7.2 Hz)]. Thus, the structure of compound 3 was identified as a 
cnidiadin by the analysis of 1D and 2D NMR experiments and by comparison of its 
spectral data with those reported in the literature (Hata et al., 1972). 
Compound 5 was obtained as an amorphous white solid with an elemental 
composition of C20H24O9, as determined from its FABMS. Comparison of the 
1H- 
and 13C-NMR data of compound 5 with those of 1-3 revealed that 5 is also a 
coumarin. However, there were significant differences in the 13C NMR spectrum as 
compared with 1. The six carbon signals of the sugar moiety were at δ 98.8, 78.1, 
77.5, 75.1, 71.4 and 62.3, suggesting that 5 was a coumarin glycoside. The carbon 
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resonances of 5 were in agreement with literature values for a β-D-glucopyranosyl 
residue. Therefore, the structure of the compound 5 was identified as (2'S)-
columbianetin-O-β-D-glucopyranoside (Shipchandler et al., 1970; Mchale et al., 
1987; Van Wagenen et al., 1988). 
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3.1.2. Structural Determination of Compound 4  
Compound 4, which is a homologous series of compounds 1 - 3, was obtained as 
an amorphous white powder with an elemental composition of C19H22O5, as 
determined from its high-resolution EIMS ([M]+ m/z 330.1467). The 1H and 13C 
NMR spectra of 4 were very similar to those of (2'S)-columbianetin (1) from 
Cnidium japonicum (Table 4) (Hata et al., 1972). However, there were significant 
differences in the 1H NMR spectrum as compared with (2'S)-columbianetin (1). 
The signals for two methyls, one methylene, and one methine were observed at δ 
1.01 (3H, d, J = 7.2 Hz), 0.85 (3H, t, J = 7.2 Hz), 1.50 (2H, m) and 2.20 (1H, m), 
respectively. Corresponding differences were found in the 13C NMR spectrum, in 
which signals were observed of a quaternary carbon at δ 175.4, two methyl carbons 
at δ 16.7 and 11.7, a methylene at δ 26.7, and a methine carbon at δ 42.1, 
respectively. These differences were explained by the presence of additional 
signals due to a 2-methylbutanoyl group in 4, which was confirmed by a HMBC 
experiment. Detailed analysis of the gDQCOSY, gHMQC, and gHMBC spectra 
indicated that 4 is O-(2-methylbutanoyl)-columbianetin.  
The remaining problem was the determination of the relative configuration of 4. 
This compound possesses asymmetric centers at C-2' and C-7'. The configuration at 
C-2' of 4 was determined as S by comparison of the optical rotation of 1 obtained 
after hydrolysis of 4 with that of the authentic compound (Scheme 4). To determine 
the configuration of C-7', 4 was synthesized by esterification of 1 with (S)-(+)-2-
methylbutanoic acid. Spectroscopic data of the synthetic compound were identical 
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with those of 4 (Scheme 5). Thus, the structure of compound 4 was assigned as 
(2'S,7'S)-O-(2-methylbutanoyl)-columbianetin. This compound has not been 
previously reported in the literature. 
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3.1.3. Structural Determination of Compound 6 
Compound 6 was isolated as an amorphous white powder that yielded 
C14H14O7S upon analysis by a combination of high-resolution ESIMS and 
13C 
NMR spectrometry. Strong absorption bands at 3415 and 1250 cm-1 in the IR 
spectrum indicated the presence of a hydrogen sulfate group. The 13C NMR 
spectroscopic data of 6 were almost identical to those of 1 (Table 4). The only 
significant difference was the downfield shift of a quaternary carbon signal for 1 
from δ 71.7 to 84.1. Its neighboring methyl carbon signals were also shifted upfield 
from δ 26.0 and 24.1 of 1 to δ 23.5 and 22.0 in 6. In addition, corresponding 
differences were observed in the 1H NMR spectra, in which two methyl proton 
signals at δ 1.37 (3H, s) and 1.24 (3H, s) in 1 were shifted downfield to δ 1.64 (3H, 
s) and 1.53 (3H, s) in 6. These changes were accommodated by replacement of the 
hydroxy group with a hydrogen sulfate group, which naturally creates a stronger 
electron-withdrawing effect than the hydroxy group. This interpretation was also 
supported by 1 and sulfate obtained after acid hydrolysis of 6 (Scheme 6). 
Detection of the sulfate was done by precipitation with BaCl2 and by a BaCl2–
KMnO4 spray test (Mitchell and Waring, 1978). Thus, the structure of 6 was 
deduced as (2'S)-columbianetin-3'-hydrogen sulfate, and this compound has also 
not yet been reported before in the literature. 
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3.1.4. Structural Determination of Compounds 7-11 
Compound 7 was isolated as an amorphous white solid and its molecular 
formula was assigned as C13H10O5 by EIMS and 
13C NMR spectrometry. The 1H 
NMR spectrum of 7 exhibited signals arising from 5,8-dioxyfurocoumarin units at 
δ 8.11 (1H, d, J = 9.9 Hz), 6.28 (1H, d, J = 9.9 Hz), 7.62 (1H, d, J = 2.3 Hz) and 
7.00 (1H, d, J = 2.3 Hz). The methoxy groups observed at δ 4.26 (3H, s) and 4.15 
(3H, s) were found to be attached to C-5 and C-8, respectively, according to long-
range C-H coupling in the HMBC experiment. On the basis of the above evidence, 
compound 7 was determined to be isopimpinellin, which was further confirmed by 
comparison with previously published NMR data (Hata et al., 1972; Elgmal et al., 
1979).  
Compound 8 was isolated as an amorphous white solid. The molecular formula 
C14H18O5 of 8 was characterized from the FABMS and 
13C NMR spectrometric 
analysis. The 1H NMR spectra of 8 indicated the presence of two methyls at δ 1.22 
and 1.20 (3H each, both s), three methylenes at δ 3.03 (2H, dd, J = 2.3, 8.9 Hz), 
2.74 (2H, t, J = 6.5 Hz) and 2.44 (2H, t, J = 6.5 Hz), an oxygenated methine at δ 
4.53 (1H, t, J = 8.9 Hz) and two aromatic protons at δ 6.76 (1H, d, J = 8.1 Hz) and 
6.17 (1H, d, J = 8.1 Hz). By extensive 2D NMR experiments, the structure of 8 was 
elucidated to be hyunganol Ⅱ, and this interpretation was further supported by 
comparison with spectroscopic data from the literature (Morikawa et al., 2004). 
A homologous series of compounds 9-11 were characterized as follows. 
Compound 9 was obtained as an amorphous white powder with an elemental 
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composition of C15H16O5, as determined from its ESIMS. The 
13C NMR spectra 
showed a carbonyl group (δ 184.3), the six carbons of a 1,3,5-oxygenated benzene 
system (δ 159.3, 157.6, 156.6, 116.6, 107.6, 99.8) and an enolic double bond (δ 
169.9, 109.1). 1H NMR signals corresponding to an aromatic ring and an enolic 
double bond were also observed at δ 7.21 (1H, s) and 6.12 (1H, s). Upon careful 
examination, these data were reminiscent of a benzopyran moiety. Detailed 
chemical structure was elucidated by 2D NMR experiments. In addition, the 
presence of 4-hydroxy-3-methylbut-2-enyl group was suggested by the 1H and 13C 
NMR spectra [δH 5.35 (1H, t, J = 7.7 Hz), 4.31 (2H, s), 3.46 (2H, d, J = 7.7 Hz), 
1.74 (3H, s); δC 135.8, 125.4, 61.6, 22.5, 21.5] and confirmed by gDQCOSY and 
gHMBC. With the aid of the above results, a literature survey showed that the 
structure of 9 was cnidimol A. Its NMR spectral data were well matched with those 
reported previously (Baba et al., 1992; Baba et al., 1994). 
Compound 10 was analyzed for C21H26O10 by a combination of FABMS and 
13C 
NMR spectrometry. The 1H NMR signals were closely related to those of 9, except 
for the presence of a sugar moiety at δ 4.31-3.21 [anomeric H: δ 4.31 (1H, br.s)]. 
The 13C NMR spectrum of 10 was also closely related to that of 9, except for the 
presence of the signals assignable to a β-glucopyranosyl moiety (δ 102.3, 78.6, 
77.7, 75.0, 71.6, 62.7). On the basis of the above evidence, and the comparison of 
data with that of the literature (Baba et al., 1994), compound 10 was determined to 
be cnidimoside A. 
 
- 51 - 
Compound 11 was isolated as an amorphous white powder that analyzed as 
C15H14O4 by a combination of high resolution FABMS ([M+H]
+ m/z 259.0970) and 
13C NMR spectrometry. The 1H and 13C NMR spectra of 11 were strikingly similar 
with those of cnidimol A (9) and cnidimoside A (10) from Cnidium japonicum 
(Baba et al., 1992; Baba et al., 1994). However, there were significant differences 
in the 1H NMR spectrum as compared with 10. The 1H NMR signals at δ 6.33 (1H, 
s) and 6.03 (1H, s) were characteristic for the compound of 11. In addition, 1H 
NMR spectrum showed the presence of a nonequivalent terminal methylene at δ 
4.74 (1H, s) and 4.68 (1H, s), an adjacent benzyl methylene at δ 2.98 (1H, dd, J = 
6.6, 13.5 Hz) and 2.85 (1H, dd, J = 6.6, 13.5 Hz), a methine linked to an oxygen 
atom at δ 4.38 (1H, t, J = 6.6 Hz) and two olefinic methyl groups at δ 2.34 (3H, s) 
and 1.81 (3H, s). A literature search showed that compound 11 reported as the 
artificial chromone of cnidimoside A (10) (Baba et al., 1994). The assignment of 
carbons and protons could be made through gDQCOSY, TOCSY, DEPT, gHMQC, 
gHMBC spectra and by comparison of the published data for related compounds. 
Thus, the structure of compound 11 was established to be 2,3-dihydro-4-hydroxy-
7-methyl-2-isopropenyl-5H-furo[3,2g][1] benzopyran-5-one.  
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Table 4. 1H and 13C NMR data for compounds 1, 4 and 6 isolated from Corydalis 
heterocarpa  
4a 6 b 1 a 
Position 
δH δC δH δC δH δC 
1 - - - - - - 
2 - 160.8 - 163.0 - 160.9 
3 6.18 (1H, d, J=9.4 Hz) 112.0 6.17 (1H, d, J=9.5 Hz) 112.2 6.20 (1H, d, J=9.5 Hz) 112.0 
4 7.60 (1H, d, J=9.4 Hz) 143.8 7.84 (1H, d, J=9.5 Hz) 146.2 7.61 (1H, d, J=9.5 Hz) 143.8 
5 7.23 (1H, d, J=8.3 Hz) 128.6 7.38 (1H, d, J=8.4 Hz) 130.2 7.26 (1H, d, J=8.3 Hz) 128.6 
6 6.71 (1H, d, J=8.3 Hz) 106.5 6.75 (1H, d, J=8.4 Hz) 107.8 6.73 (1H, d, J=8.3 Hz) 106.6 
7 - 163.7 - 165.4 - 163.5 
8 - 112.8 - 114.3 - 113.0 
9 - 151.0 - 152.3 - 151.1 
10 - 113.4 - 114.8 - 113.9 
1' 
3.36 (1H, dd, J=16.5, 9.5 Hz) 
3.28 (1H, dd, J=16.5, 7.7Hz) 
27.6 3.42 (2H, m) 28.4 3.31 (2H,dd, J=9.0, 4.8 Hz) 27.6 
2' 5.07 (1H,dd, J=9.5,7.7 Hz) 88.9 5.03 (1H, dd, J=9.6, 7.7Hz) 91.1 4.79 (1H, t, J=9.0 Hz) 91.3 
3' - 81.6 - 84.1 - 71.7 
4'/5' 1.56 (3H, s) / 1.51 (3H, s) 
22.3  
/21.1 
1.64 (3H ,s) / 1.53 (3H, s) 
23.5  
/22.0 
1.37 (3H, s) / 1.24 (3H, s) 
26.0  
/24.1 
6' - 175.4     
7' 2.20 (1H, m) 42.1     
8' 1.50 (1H, m), 1.35 (1H, m) 26.7     
9' 0.85 (3H, t, J=7.2 Hz) 11.7     
10' 1.01 (3H, d, J=7.2 Hz) 16.7     
a, b Measured in CDCl3 and CD3OD at 300 and 75 MHz, respectively. Assignments were 
aided by 1H gDQCOSY, TOCSY, DEPT, gHMQC, and gHMBC experiments. 
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3.1.5. Spectral Data 
(2'S)-columbianetin (1): amorphous white solid; mp 160 - 163 ºC; [α]D
25 + 264 
(c 1.1, MeOH); EIMS m/z 246 [M]+; NMR data, see Table 4. 
 
Libanoridin (2): amorphous white solid; mp 129 - 132 ºC; [α]D
25 + 252 (c 1.0, 
CHCl3); EIMS m/z 288 [M]
+; 1H NMR (300 MHz, CDCl3) δ: 7.60 (1H, d, J = 9.6 
Hz, H-4), 7.24 (1H, d, J = 8.3 Hz, H-5), 6.72 (1H, d, J = 8.3 Hz, H-6), 6.18 (1H, d, 
J = 9.6 Hz, H-3), 5.12 (1H, dd, J = 9.6, 7.8 Hz, H-2'), 3.35 (1H, dd, J = 16.5, 9.6 
Hz, H-1'a), 3.26 (1H, dd, J = 16.5, 7.8 Hz, H-1'b), 1.97 (3H, s, H-7'), 1.55 (3H, s, 
H-4'/-5'), 1.50 (3H, s, H-4'/-5'); 13C NMR (75 MHz, CDCl3) δ: 170.0 (C, C-6'), 
163.6 (C, C-7), 160.8 (C, C-2), 151.0 (C, C-9), 143.8 (CH, C-4), 128.7 (CH, C-5), 
113.3 (C, C-10), 112.9 (C, C-8), 112.1 (CH, C-3), 106.6 (CH, C-6), 88.6 (CH, C-2'), 
82.0 (C, C-3'), 27.6 (CH2, C-1'), 22.3 (CH3, C-7'), 22.0 (CH3, C-4'/-5'), 21.0 (CH3, 
C-4'/-5'). 
 
Cnidiadin (3): amorphous white solid; mp 138 - 142 ºC; [α]D
25 + 205 (c 1.0, 
CHCl3); EIMS m/z 316 [M]
+; 1H NMR (300 MHz, CDCl3) δ: 7.60 (1H, d, J = 9.6 
Hz, H-4), 7.24 (1H, d, J = 8.3 Hz, H-5), 6.71 (1H, d, J = 8.3 Hz, H-6), 6.18 (1H, d, 
J = 9.6 Hz, H-3), 5.08 (1H, dd, J = 9.5, 7.7 Hz, H-2'), 3.36 (1H, dd, J =16.4, 9.5 Hz, 
H-1'a), 3.28 (1H, dd, J = 16.4, 7.7 Hz, H-1'b), 2.40 (1H, m, H-7'), 1.56 (3H, s, H-5'), 
1.50 (3H, s, H-4'), 1.04 (3H, d, J = 7.2 Hz, H-8'/-9'), 1.03 (3H, d, J = 7.2 Hz , H-8'/-
9'); 13C NMR (75MHz, CDCl3) δ: 176.0 (C, C-6'), 163.8 (C, C-7), 160.9 (C, C-2), 
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151.0 (C, C-9), 143.9 (CH, C-4), 128.7 (CH, C-5), 113.4 (C, C-10), 112.9 (C, C-8), 
112.0 (CH, C-3), 106.5 (CH, C-6), 88.9 (CH, C-2'), 81.6 (C, C-3'), 34.9 (CH, C-7'), 
27.5 (CH2, C-1'), 22.2 (CH3, C-5'), 21.0 (CH3, C-4'), 19.0 (CH3, C-8'/-9'), 18.9 (CH3, 
C-8'/-9'). 
 
(2'S,7'S)-O-(2-methylbutanoyl)-columbianetin (4): amorphous white solid; mp 
88 - 91 ºC; [α]D
20 + 194 (c 0.67, CHCl3); HREIMS m/z 330.1467 [M]
+ (calcd. for 
C19H22O5, 330.1467); NMR data, see Table 4. 
 
(2'S)-columbianetin-O-β-D-glucopyranoside (5): amorphous white solid; 116 
– 119 ºC; [α]D
20 + 152 (c 0.32, MeOH); FABMS m/z 409 [M+H]+; 1H NMR (300 
MHz, CD3OD) δ: 7.85 (1H, d, J = 9.5 Hz, H-4), 7.38 (1H, d, J = 8.4 Hz, H-5), 6.75 
(1H, d, J = 8.4 Hz, H-6), 6.18 (1H, d, J = 9.5 Hz, H-3), 4.92 (1H, t, J = 9.9 Hz, H-
2'), 4.57 (1H, br.s, H-1''), 3.48 (2H, m, H-6''), 3.36 (1H, m, H-5''), 3.34 (2H, m, H-
1'), 3.33 (1H, m, H-4''), 3.14 (1H, m, H-3''), 3.11 (1H, m, H-2''), 1.37 (3H, s, H-4'/-
5'), 1.36 (3H, s, H-4'/-5'); 13C NMR (75MHz, CD3OD) δ: 165.4 (C, C-7), 163.1 (C, 
C-2), 152.4 (C, C-9), 146.2 (CH, C-4), 130.1 (CH, C-5), 115.4 (C, C-10), 114.4 (C, 
C-8), 112.2 (CH, C-3), 107.8 (CH, C-6), 98.8 (CH, C-1''), 91.8 (CH, C-2'), 79.1 (C, 
C-3'), 78.1 (CH, C-5''), 77.5 (CH, C-3''), 75.1 (CH, C-2''), 71.4 (CH, C-4''), 62.3 
(CH2, C-6''), 28.3 (CH2, C-1'), 23.8 (CH3, C-4'/-5'), 22.4 (CH3, C-4'/-5'). 
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(2'S)-columbianetin-3'-hydrogen sulfate (6): amorphous white solid; mp 160 - 
163 ºC; [α]D
20 + 156 (c 0.17, MeOH); HRESIMS (negative-ion mode) m/z 
325.0388 [M-H]- (calcd. for C14H13O7S, 325.0382); NMR data, see Table 4. 
 
Isopimpinellin (7): Amorphous white solid; [α]D
25: + 9.52 (c 0.21, MeOH); 
EIMS m/z 246 [M]+; 1H NMR (300 MHz, CDCl3) δ: 8.11 (1H, d, J = 9.9 Hz, H-4), 
7.62 (1H, d, J = 2.3 Hz, H-2'), 7.00 (1H, d, J = 2.3 Hz, H-1'), 6.28 (1H, d, J = 9.9 
Hz, H-3), 4.26 (3H, s, H-5-OCH3), 4.15 (3H, s, H-8-OCH3); 
13C NMR (75MHz, 
CDCl3) δ: 160.4 (C, C-2), 149.8 (C, C-7), 145.0 (CH, C-2'), 144.1 (C, C-5), 143.5 
(C, C-9), 139.3 (CH, C-4), 128.0 (C, C-8), 114.7 (C, C-6), 112.7 (CH, C-3), 107.5 
(C, C-10), 105.0 (CH, C-1'), 61.7 (C-8-OCH3), 60.8 (C-5-OCH3). 
 
Hyunganol Ⅱ (8): Amorphous white solid; [α]D
20 + 22.33 (c 0.36, MeOH); 
FABMS m/z 267 [M+H]+; 1H NMR (300 MHz, CD3OD) δ: 6.76 (1H, d, J = 8.1 Hz, 
H-9), 6.17 (1H, d, J = 8.1 Hz, H-8), 4.53(1H, t, J = 8.9 Hz, H-2'), 3.03 (2H, dd, J = 
2.3, 8.9 Hz, H-1'), 2.74 (2H, t, J = 6.5 Hz, H-4), 2.44 (2H, t, J = 6.5 Hz, H-3), 1.22 
(3H, s, H-5'), 1.20 (3H, s, H-4'); 13C NMR (75 MHz, CD3OD) δ: 182.5 (C, C-2), 
160.8 (C, C-7), 152.8 (C, C-5), 130.5 (CH, C-9), 123.1 (C, C-10), 114.9 (C, C-6), 
101.7 (CH, C-8), 90.7 (CH, C-2'), 72.6 (C, C-3'), 40.4 (CH2, C-3), 29.5 (CH2, C-1'), 
27.5 (CH2, C-4), 25.3 (CH3, C-4'), 25.1 (CH3, C-5'). 
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Cnidimol A (9): Amorphous white solid; [α]D
20 – 18.00 (c 0.50, MeOH); ESIMS 
m/z 277 [M+H]+; 1H NMR (300 MHz, CD3OD) δ: 7.21 (1H, s, H-8), 6.12 (1H, s, 
H-3), 5.35 (1H, t, J = 7.7 Hz, H-2'), 4.31 (2H, s, H-5'), 3.46 (2H, d, J = 7.7 Hz, H-
1'), 2.31 (3H, s, 2-Me), 1.74 (3H, s, H-4'); 13C NMR (75 MHz, CD3OD) δ: 184.3 (C, 
C-4), 169.9 (C, C-2), 159.3 (C, C-7), 157.6 (C, C-5), 156.6 (C, C-9), 135.8 (C, C-
3'), 125.4 (CH, C-2'), 116.6 (C, C-6), 109.1 (CH, C-3), 107.6 (C, C-10), 99.8 (CH, 
C-8), 61.6 (CH2, C-5'), 22.5 (CH2, C-1'), 21.5 (CH3, C-4'), 20.4 (CH3, 2-Me). 
 
Cnidimoside A (10): Amorphous white solid; [α]D
20 – 3.16 (c 0.32, MeOH); 
FABMS m/z 439 [M+H]+; 1H NMR (300 MHz, CD3OD) δ: 6.29 (1H, s, H-8), 5.98 
(1H, s, H-3), 5.46 (1H, t, J = 7.0 Hz, H-2'), 4.65 (1H, d, J = 12.1 Hz, H-5'a), 4.32 
(1H, d, J = 12.1 Hz, H-5'b), 4.31 (1H, br.s, H-1''), 3.89 (1H, dd, J = 1.9, 11.6 Hz, 
H-6''a), 3.72 (1H, dd, J = 4.5, 11.6 Hz, H-6''b), 3.37 (1H, m, H-4''), 3.35 (2H, d, J = 
7.0 Hz, H-1'), 3.34 (1H, m, H-5''), 3.32 (1H, m, H-3''), 3.21 (1H, m, H-2''), 2.31 (3H, 
s, 2-Me), 1.76 (3H, s, H-4'); 13C NMR (75 MHz, CD3OD) δ: 183.6 (C, C-4), 168.6 
(C, C-2), 164.0 (C, C-7), 159.6 (C, C-5), 157.6 (C, C-9), 132.3 (C, C-3'), 128.7 
(CH, C-2'), 112.1 (C, C-6), 108.6 (CH, C-3), 104.5 (C, C-10), 102.3 (CH, C-1''), 
94.3 (CH, C-8), 78.6 (CH, C-5''), 77.7 (CH, C-3''), 75.0 (CH, C-2''), 71.6 (CH, C-
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2,3-dihydro-4-hydroxy-7-methyl-2-isopropenyl-5H-furo[3,2g][1] 
benzopyran-5-one (11): Amorphous white solid; mp 155 - 158 ºC; [α]D
20 + 20 (c 
0.25, MeOH); HRFABMS m/z 259.0970 [M+H]+ (calcd. for C15H14O4, 259.0970); 
1H NMR (300 MHz, CD3OD) δ: 6.33 (1H, s, H-8), 6.03 (1H, s, H-3), 4.74 (1H, s, 
H-4'a), 4.68 (1H, s, H-4'b), 4.38 (1H, t, J = 6.6 Hz, H-2'), 2.98 (1H, dd, J = 6.6, 
13.48 Hz, H-1'a), 2.85 (1H, dd, J = 6.6, 13.48 Hz, H-1'b), 2.34 (3H, s, 2-Me), 1.81 
(3H, s, H-5'); 13C NMR (75 MHz, CD3OD) δ: 183.8 (C, C-4), 164.2 (C, C-7), 168.8 
(C, C-2), 160.5 (C, C-5), 157.9 (C, C-9), 148.5 (C, C-3'), 110.2 (C, C-6), 111.0 
(CH2, C-4'), 108.7 (CH, C-3), 104.7 (C, C-10), 94.4 (CH, C-8), 76.2 (CH, C-2'), 
29.7 (CH2, C-1'), 20.3 (CH3, 2-Me), 17.8 (CH3, C-5'). 
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3.2. Secondary Metabolites Isolated from Vitex rotundifolia 
The solvent extract of V. rotundifolia was partitioned with CH2Cl2 and H2O. 
Each layer was further partitioned with n-hexane/85% aq. MeOH and n-
BuOH/H2O, respectively. The n-BuOH, 85% aq. MeOH and n-hexane fractions 
were purified by various types of column chromatography, TLC, and HPLC, using 
different solvent combinations, to yield nineteen compounds including five new 
compounds (20 and 23-26) (Fig. 6 and 7). 
 









12. R1, R4, R5 = OH,  R2, R3 = H
13. R1, R3 =OMe,  R2 = H,  R4, R5 
= OH
14. R1 - R3, R5 = OMe,  R4 = OH























16. R1 = H,  R2 = COCH3
17. R1 = COCH3,  R2 = H























Figure 6. Chemical structure of compounds 12-21 isolated from Vitex rotundifolia. 
 

























































































29. R1 = H,  R2 = CH3
30. R1 = CH3,  R2 = H
 
Figure 7. Chemical structure of compounds 22-30 isolated from Vitex rotundifolia. 
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3.2.1. Structural Determination of Compounds 12-15 
Compound 12 was isolated as a yellow solid. The molecular formula of 12 was 
established as C15H10O6 on the basis of EIMS and 
13C NMR spectrometry.  The IR 
spectrum of 12 showed a broad hydroxyl and α,β-unsaturated carbonyl absorption 
at 3,368 cm-1 and 1,655 cm-1, respectively. The 1H and 13C NMR spectra revealed 
signals typical of a flavonoid. The 1H NMR signals due to the flavonoid skeleton [δ 
7.35 (1H, d, J = 8.3 Hz), 7.34 (1H, br s), 6.88 (1H, d, J = 8.3 Hz), 6.51 (1H, s), 6.41 
(1H, br s), 6.18 (1H, br s)] showed the characteristic pattern of luteolin. Therefore, 
compound 12 was determined as luteolin and was further confirmed by assignment 
of NMR data previously reported (Yoshioka et al., 2004; Loizzo et al., 2007). 
Compounds 13-15 were isolated as pale yellow solids and the 1H and 13C NMR 
signals of 13-15 were quite similar to those of 12, except for the methoxy groups. 
Thus, compounds 13-15 were identified as quercetin 3,7-dimethyl ether (13) 
(Sadhu et al., 2006), vitexicarpin (14) (Yoshioka et al., 2004), and artemetin (15) 
(Iinuma et al., 1980; Rahman et al., 1988; Ahmad et al., 1995; Yoshioka et al., 
2004), by the analysis of NMR data and by comparison with published data. 
Among these, this is the first report of compound 13 from V. rotundifolia. 
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3.2.2. Structural Determination of Compounds 16-18 
Compound 16 was obtained as a colorless syrup. In the EIMS, 16 did not show a 
molecular ion peak but showed a fragment ion peak at m/z 304 [M-CH3COOH]
+.  
The molecular formula of 16 was determined to be C22H36O4 by EIMS and 
13C 
NMR spectrometry. The 1H NMR spectrum of 16 indicated signals due to four 
tertiary methyl groups [δ 1.21 (3H, s), 1.15 (3H, s), 1.05 (3H, s), 1.05 (3H, s)], one 
secondary methyl group [δ 0.94 (3H, d, J = 7.0 Hz)], one acetyl groups [δ 2.09 (3H, 
s)], one vinylic group [δ 5.84 (1H, dd, J = 17.4, 10.7 Hz), 5.15 (1H, dd, J = 17.4, 
1.5 Hz), 5.01 (1H, dd, J = 10.7, 1.5 Hz)], and two oxygenated methylene protons [δ 
4.80 (2H, dd, J = 12.5, 3.1 Hz), 4.18 (2H, d, J = 3.1 Hz)]. The 13C NMR spectrum 
of 16 gave 22 carbon signals, including one carbonyl group (δ 172.8), one tetra-
substituted olefinic bond (δ 139.6, 137.1), one vinylic group (δ 145.9, 112.3), one 
oxygenated quaternary carbon (δ 73.8), and two oxygenated methine carbons (δ 
76.9, 65.2), suggesting 16 to be a diterpene with a 3-hydroxy-3-methyl-1-propenyl 
group and one acetyl group. These 1H and 13C NMR spectroscopic signals were 
assigned with the aid of 2D NMR techniques, and the structure of 16 was 
determined as vitetrifolin F, and was further supported by comparison of the 
obtained  spectroscopic data with those reported in the literature (Ono et al., 2001). 
Compounds 17 and 18 were obtained as colorless needles and a colorless syrup, 
respectively. The 1H NMR spectra of 17 were similar to those of 16, except that the 
signal due to an acetyl group moved and signals assignable to H-6 and H-7 in 17 
were shifted down- and up-field by 1.38 ppm and 1.18 ppm, respectively, in 
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comparison with those of 16. The 1H NMR spectra of 18 was also similar to that of 
16, except that the signal due to another new acetyl group appeared and signals 
assignable to H-6 in 18 was shifted downfield by 1.49 ppm, in comparison with 
those of 16. Therefore, 17 and 18 were recognized as vitetrifolin E (17) and 
vitetrifolin D (18), respectively, by comparison with structures reported in the 
literature (Ono et al., 2001). 
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3.2.3. Structural Determination of Compounds 19 and 21 
Compound 19 was isolated as a pale yellow solid. The molecular formula of 19 
was determined to be C22H34O5 by EIMS and 
13C NMR spectrometry. The IR 
spectrum of 19 exhibited the presence of hydroxy (3509 cm-1), acetoxyl (1734 cm-
1), and α,β-unsaturated γ-lactone (1779 cm-1) groups. The 1H NMR spectrum of 19 
contained signals for four tertiary methyls [δ 2.04, 1.23, 0.99, 0.95 (3H each, all s)], 
a methine [δ 5.35 (1H, q, J = 2.5 Hz)] on a carbon bearing an acetoxyl group [δ 
2.04 (3H, s)], a methylene proton [δ 4.73 (2H, d, J = 1.7 Hz)] and an olefinic 
proton [δ 5.82 (1H, s)] of the α,β-unsaturated γ-lactone system (Table 5). On the 
basis of these results, it was concluded that 19 is vitexilactone, and this conclusion 
was further supported by comparison of the spectroscopic data with literature 
values (Kondo et al., 1986; Hoberg et al., 1999; Ono et al., 2001). 
Compound 21 was obtained as an amorphous white solid, and its ESIMS 
afforded a [M-H]- peak at m/z 407, suggesting the molecular formula, C23H36O6. 
The 1H and 13C NMR spectra of 21 were almost superimposable on those of 19, 
apart from the chemical shifts of signals due to the olefinic group [δH 6.75 (1H, d, J 
= 1.2 Hz, H-14); δC 141.4 (C-14), 139.1 (C-13) in 21; δH 5.82 (1H, s, H-14), δC 
170.9 (C-13), 114.8 (C-14) in 19], which exhibited the replacement of a β-
substituted butenolide ring in 19 by an α-substituted butenolide ring. The signal 
due to a methoxyl group appeared at δ 3.57 (3H, s). Accordingly, by comparison to 
literature data, 21 was defined as (5S*,6R*,8R*,9R*,10S*)-6-acetoxy-9-hydroxy-15-
methoxy-13(14)-labden-16,15-olide (Ono et al., 2001).  
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3.2.4. Structural Determination of Compound 20 
Compound 20 was obtained as a pale yellow solid. The molecular formula of 20 
was determined to be C22H34O6 by a combination of high resolution ESIMS ([M-
H]- m/z 393.2286) and 13C NMR spectrometry. The 1H NMR spectrum of 20 was 
similar to that of 19, with the exception that a signal due to a hydroxyl group 
appeared at δ 5.98 (1H, s), while the signal at δ 4.73 (2H, d, J = 1.7 Hz) assignable 
to an H-16 disappeared. This suggestion was supported by the 13C NMR spectral 
data. Comparing the 13C NMR spectra of 20 with those of 19, the signals of C-14 
and C-16 in 19 were shifted downfield from δ 114.8 and 73.2 of 19 to δ 117.3 and 
98.9 in 20, respectively, whereas those of C-13 and C-15 were shifted upfield from 
δ 170.9 and 170.9 of 19 to δ 170.3 and 170.5 in 20, respectively, and the other 
carbon signals were quite similar to those of 19 (Table 5).  
The relative stereochemistry in 20 was examined from its NOESY spectral data. 
The NOE correlation between H-20/H-19, H-20/H-11a, and H-20/H-8 were 
observed in 20. In addition, NOE correlations between H-18/H-19, H-18/H-6, and 
H-18/H-5 (Fig. 8) were observed. On the basis of these data, the configurations at 
C-5, C-6, C-8, C-9 and C-10 were determined to be S*, R*, R*, R* and S*, 
respectively. Thus, 20 was determined as (5S*,6R*,8R*,9R*,10S*)-6-acetoxy-9-
hydroxy-16-hydroxy-13(14)-labden-16,15-olide. This compound has not been 

























Figure 8. NOESY correlation of compound 20 isolated from Vitex rotundifolia. 
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3.2.5. Structural Determination of Compound 22 
Compound 22, C25H26N2O3 (FABMS m/z 403 [M+H]
+), a neutral compound, did 
not exhibit any characteristic UV absorption. The 1H NMR spectrum of 22 
confirmed the presence of 15 aromatic protons incorporated in a benzoyl [δ 7.70 
(2H, d, J = 11.3 Hz), 7.50 (1H, t, J = 11.3 Hz), 7.42 (2H, t, J = 11.3 Hz)] and two 
benzyl groups [δ 7.31 (2H, t, J = 11.3 Hz), 7.26 (2H, d, J = 11.3 Hz), 7.25 (1H, t, J 
= 11.3 Hz), 7.16 (2H, t, J = 11.3 Hz), 7.12 (1H, t, J = 11.3 Hz), 7.06 (2H, d, J = 
11.3 Hz)]. The 13C NMR spectrum of 22 showed the presence of two carbonyls (δ 
170.6, 167.0) in addition to three methylenes (δ 63.6, 38.8, 36.9) and two aliphatic 
methines (δ 55.3, 52.9). It was apparent from their chemical shifts that the three 
lowfield aliphatic carbons were situated next to hetero-atoms. All of the signals in 
the 1H and 13C NMR spectrum could be unequivocally assigned only after the 
structure of aurantiamide had been established from its literature values (Banerji 
and Ray, 1981; Wahidulla et al., 1991; Ferreira et al., 1995; Lu et al., 1999; Isshiki 
et al., 2001). This is the first report of compound 22 identified from this halophyte. 
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3.2.6. Structural Determination of Compound 23 
Compound 23 was obtained as a pale yellow solid, and its high-resolution 
FABMS afforded a [M+Na]+ peak at m/z 247.2993, suggesting the molecular 
formula, C20H36O3. The 
1H NMR spectrum of 23 contained signals for four tertiary 
methyls [δ 1.25, 1.18, 1.16, 0.91 (3H each, all s)], one secondary methyl [δ 0.80 (d, 
J = 6.9 Hz)] and one vinylic group [δ 5.87 (dd, J = 17.4, 10.8 Hz), 5.16 (dd, J = 
17.4, 1.5 Hz), 5.00 (dd, J = 10.8, 1.5 Hz)]. The 13C NMR spectrum indicated the 
presence of 20 carbons including two quaternary carbons (δ 78.0, 74.4) and one 
secondary carbon (δ 76.9) bearing hydroxy group (Table 6). The above spectral 
data, coupled with the molecular formula, indicated that 23 was a bicyclic 
diterpenoid having two tertiary hydroxy groups, one secondary hydroxy group and 
one vinyl group. From the above observations, compound 23 was similar to 
characteristics of the known compound, pleuroziol, isolated from the liverwort 
Pleurozia gigantean (Asakawa et al., 1990). The only difference was that H-3 in 
pleuroziol was replaced by a hydroxy group in 23, resulting in the presence of a 
downfield carbon signal C-3 (δ 76.9) in 23. Corresponding change in the 1H NMR 
spectra was found at δ 3.46 (1H, t, J = 2.5 Hz) in 23. Thus, the above data indicated 
that 23 is a 3-hydroxy derivative of pleuroziol.  
In order to clarify the stereochemistry, the difference NOE was measured. The 
NOE correlations between H-6/H-8, H-10/H-19, H-10/H-2a, H-3/H-2, H-3/H-18, 
H-20/H-1a, H-20/H-17 and H-16/H-17 were observed in NOESY spectra of 23 
(Fig. 9). The 3-hydroxy group was confirmed to be α orientation by the small 
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coupling constant (J = 2.5 Hz) of the H-3 this is due to H-2/H-3 coupling constant. 
Therefore, the structure of 23 was represented as 3α-hydroxy pleuroziol. This 




















Figure 9. NOESY correlation of compound 23 isolated from Vitex rotundifolia. 
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3.2.7. Structural Determination of Compound 24 
Compound 24 was obtained as a colorless solid. The 13C NMR and EIMS ([M]+ 
m/z 290) data indicated that the molecular formula for 24 was C20H34O, with an 
unsaturation index of four. The 1H NMR data of 24 showed the signals of five 
tertiary methyls [δ 1.34, 1.10, 1.07, 0.81, 0.75 (3H each, all s)], one vinylic group 
[δ 5.91 (1H, ddd, J = 17.9, 11.0, 1.8 Hz), 4.94 (1H, dd, J = 11.0, 1.0 Hz), 4.93 (1H, 
dd, J = 17.9, 1.0 Hz)]. The 13C NMR and DEPT spectra showed the presence of 
five methyl carbons, night methylene carbons, two methine carbons and four 
quaternary carbons. The 13C NMR spectra also indicated the presence of one 
vinylic group (δ 147.0, 109.8) and two carbons linked to oxygen (δ 77.5, 72.4). On 
the basis of the absence of triple bond signals in its spectra, an oxo-tricyclic 
structure was proposed for this compound. 1H NMR and 13C NMR assignments 
(Table 6) together with the results of the gDQCOSY, TOCSY, gHMQC, gHMBC 
and NOESY experiments led for 24 to a manoyl oxide (Bower and Rowe, 1967; 
Cheng and Rudloffa,b, 1970; Anthonsen and Bergland 1973; Tabacchi et al., 1975; 
Almqvist et al., 1975; Zhou et al., 1995). The problematic aspect of the structure 
elucidation was the assignment at the five asymmetric centers, C-5, C-8, C-9, C-10 
and C-13. The cis-stereochemistry at the junction of the rings B and C could be 
deduced from the chemical shift of C-17 (δ 32.5) when compared to that of manoyl 
oxide (δ 25.5). The NOESY experiment confirmed the proposed cis-configuration 
of the moiety, with correlation between H-14/H-7b, H-14/H-11b, H-14/H-12a, and 
H-15/H-16. In addition, correlations between H-20/H-19, H-20/H-17, and H-20/H-
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6b were observed in NOESY spectra of 24 (Fig. 10). Thus, the structure of 24 was 
determined as 9αH-manoyl oxide, which is a stereoisomer of manoyl oxide at the 






















Figure 10. NOESY correlation of compound 24 isolated from Vitex rotundifolia. 
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3.2.8. Structural Determination of Compounds 25 and 26 
Compound 25 was isolated as a colorless solid. The molecular formula of 25 was 
established as C20H32O2 on the basis of high-resolution ESIMS ([M+Na]
+ m/z 
327.2299) data. The 1H NMR and 13C NMR data of 25 showed the presence of an 
isopropyl [δC 32.1, 17.4, 17.1; δH 1.86 (1H, m), 0.96 (3H, d, J = 6.9 Hz), 0.94 (3H, 
d, J = 6.9 Hz)], three tertiary methyls [δC 33.2, 22.2, 17.0; δH 1.05, 0.86, 0.82, (3H 
each, all s)], and a peroxy bridge between two fully substituted sp3 carbon atoms (δ 
81.3, 79.3). Two deshielded carbon resonances at δ 133.8 and 133.4 correlated with 
two deshielded proton resonances at δ 6.57 (1H, d, J = 8.8 Hz) and 6.45 (1H, d, J = 
8.8 Hz), respectively, and were assigned to a cis-disubstituted double bond (Table 
7). The lack of carbonyl resonances in the 13C NMR spectrum indicated that four 
rings were required to account for the remaining degrees of unsaturation on the 
molecule. All of these data were very similar to those of methyl 2α-abieta-11(12)-
ene-9α,13α-endoperoxyl malonate isolated from a C. purpurea except for the 
presence of an additional malonate moiety (Chamy et al., 1993), and could be 
accommodated in the abietane carbon skelecton as depicted in 25. The structure of 
25 was thus established as abieta-11(12)-ene-9α,13α-endoperoxide. 
Compound 26 was also isolated as a colorless solid and possessed the molecular 
formula C20H32O2, as determined from its high-resolution ESIMS ([M+Na]
+ m/z 
327.2292). Its 1H NMR and 13C NMR data were very similar to those of 25 (Table 
7). The observed differences between the NMR spectroscopic data of 25 and 26 
were consistent with a change in the orientation of the peroxide bridge. The largest 
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difference was shown at C-5, where a deshielding effect of ∆δC + 3.5 was due to a 
γ-gauche effect. The shielding effect of ∆δC – 2.2 on C-20 was due to the 
disappearance of the γ-gauche effect (Chamy et al., 1993). Therefore, the structure 
of 26 was determined as abieta-11(12)-ene-9β,13β-endoperoxide.  
These compounds 25 and 26 have not been reported in the literature before.  
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3.2.9. Structural Determination of Compounds 27-30 
Compound 27 showed a [M+Na]+ molecular peak at m/z 327.2297 (calcd. for 
C20H32O2Na, 327.2300) in the HRESIMS. The 
1H NMR spectra indicated signals 
due to three tertiary methyl protons [δ 1.06, 0.86, 0.81 (3H each, all s)], two 
secondary methyl protons [δ 0.95 (3H, d, J = 6.8 Hz), 0.89 (3H, d, J = 6.8 Hz)] and 
two oxygenated methine protons [δ 3.32 (1H, d, J = 3.0 Hz), 2.99 (1H, d, J = 3.0 
Hz)]. The 13C NMR spectra showed 20 carbon signals, including two oxygenated 
methine carbons (δ 54.7, 49.4) and two oxygenated quaternary carbons (δ  68.0, 
58.9). These 1H and 13C NMR spectroscopic signals were assigned with the aid of 
gDQCOSY, NOESY, gHMQC and gHMBC experiments. On the basis of above 
results, the structure of 27, possessing two epoxy rings, was determined to be 
abieta-9(11):12(13)-di-α-epoxide, previously isolated from the V. rotundifolia 
(Sakurai et al., 1999). 
Compound 28 was isolated as colorless needles. The molecular formula of 28 
was determined to be C20H30O by FABMS and 
13C NMR spectrometry. The 1H 
NMR spectra contained signals for three tertiary methyls [δ 1.17, 0.93, 0.91 (3H 
each, all s)], two secondary methyls [δ 1.24 (3H, d, J = 6.9 Hz), 1.22 (3H, d, J = 6.9 
Hz)], two methines [δ 3.10 (1H, sept, J = 6.9 Hz), 1.31 (1H, dd, J = 12.4, 2.3 Hz)], 
and two olefinic methines [δ 6.81 (1H, s), 6.61 (1H, s)]. The 13C NMR spectra 
showed 20 carbon signals, including one phenyl group. These 1H and 13C NMR 
spectroscopic signals were assigned with the aid of 2D NMR experiments, and the 
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structure of 28 was determined as ferruginol, and was further supported by 
literature survey (Ulubelen, 1990; Chang et al., 2001). 
Compounds 29 and 30 were isolated as colorless solids and possessed the same 
molecular formula, C30H48O. Compounds 29 and 30 were identified as β-
amyrenone (29) and α-amyrenone (30), respectively, by a combination of 1D/2D 
NMR experiments and comparison with the literature data (Seo et al., 1975; Seo et 
al., 1981; Yan et al., 1989; Shiojima et al., 1995; Humberto et al., 2004). These 
compounds 29 and 30 are the first report of these substances from halophytes such 
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Table 5. 1H and 13C NMR data for compounds 19 and 20 isolated from Vitex rotundifolia 
20 19 
Position 
δH δC δH δC 
1 1.45 (2H, m)  33.7 1.43 (2H, m)  33.7 
2 1.48 (2H, m) 18.6 1.47 (2H, m) 18.7 
3 1.35 (2H, m) 43.6 1.25 (2H, m) 43.6 
4 - 34.1 - 34.1 
5 1.51 (1H, m) 47.8 1.55 (1H, d, J=2.5 Hz) 47.7  
6 5.37 (1H, q, J=2.5, 2.5 Hz) 69.7 5.35 (1H, q, J=2.5 Hz) 69.8 
7 1.58 (2H, m) 36.1 1.61 (2H, m) 36.1  
8 2.13 (1H, m) 32.2 2.11 (1H, m) 32.1  
9 - 77.6 - 76.4 
10 - 43.7 - 43.8 
11 
2.13 (1H, m) 
1.79 (1H, m) 
31.5 
1.95 (1H, ddd, J=14.3, 9.4, 7.2 Hz) 
1.72 (1H, ddd, J=14.3, 9.4, 7.2 Hz) 
31.7 
12 2.53 (2H, m) 24.3 2.48 (2H, dd, J=9.4, 7.2 Hz) 25.5 
13 - 170.3 - 170.9 
14 5.86 (1H, s) 117.3 5.82 (1H, s) 114.8 
15 - 170.5 - 170.9 
16 5.98 (1H, s) 98.9 4.73 (2H, d, J=1.7 Hz) 73.2 
17 0.91 (3H, d, J=6.6 Hz) 16.2 0.88 (3H, d, J=6.6 Hz) 16.2 
18 0.96 (3H, s) 33.7 0.95 (3H, s) 33.7 
19 1.01 (3H, s) 23.7 0.99 (3H, s) 23.8 
20 1.26 (3H, s) 19.0 1.23 (3H, s) 19.1 
6-COCH3 2.05(3H, s) 22.0 2.04(3H, s) 22.0  
6-COCH3 - 169.6 - 170.3 
Measured in CDCl3 at 300 and 75 MHz, respectively. Assignments were aided by 
1H 
gDQCOSY, TOCSY, DEPT, gHMQC, and gHMBC experiments. 
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Table 6. 1H and 13C NMR data for compounds 23 and 24 isolated from Vitex rotundifolia 
23a 24b 
Position 
δH δC δH δC 
1 1.79 (1H, m) , 1.25 (1H, m) 19.4 1.50 (1H, m), 1.01 (1H, m) 37.1 
2 
1.98 (1H, tt, J=13.7, 3.4 Hz)  
1.57 (1H, m) 
29.8 1.65 (1H, m), 1.39 (1H, m) 19.0 
3 3.46 (1H, t, J=2.5 Hz) 76.9  1.32 (1H, m), 1.07 (1H, m) 42.5 
4 - 43.7 - 33.4 
5 - 78.0  1.00 (2H, m) 47.4 
6 2.28 (2H, m) 30.4  1.51 (1H, m), 1.21 (1H, m) 21.4 
7 1.45 (2H, m) 29.3 2.06 (1H, m), 1.30 (1H, m) 35.6 
8 1.64 (1H, m) 38.4 - 77.5 
9 - 39.8 1.09 (1H, m) 55.5 
10 1.69 (1H, m) 43.5 - 38.2 
11 1.76 (1H, m), 1.20 (1H, m) 31.0 1.69 (1H, m), 1.53 (1H, m) 18.7 
12 1.72 (1H,m), 1.43 (1H,m) 37.9 
2.03 (1H, ddd, J=13.5, 7.2, 6.3 Hz) 
1.31 (1H, m) 
33.5 
13 - 74.4 - 72.4 
14 5.87 (1H, dd, J=17.4, 10.8 Hz) 146.0 5.91 (1H, ddd, J=17.9, 11.0, 1.8 Hz) 147.0 
15 
5.16 (1H, dd, J=17.4, 1.5 Hz) 
5.00 (1H, dd, J=10.8, 1.5 Hz) 
111.8 
4.94 (1H, dd, J=11.0, 1.0 Hz) 
4.93 (1H, dd, J=17.9, 1.0 Hz) 
109.8 
16 1.25 (3H, s) 28.2 1.10 (3H, s) 32.9 
17 0.80 (3H, d, J=6.9 Hz) 16.5 1.34 (3H, s) 32.5 
18 1.18 (3H, s) 22.0 0.81 (3H, s) 33.3 
19 1.16 (3H, s) 21.9 0.75 (3H, s) 21.8 
20 0.91 (3H, s) 30.0 1.07 (3H, s) 25.0 
aMeasured in CD3OD at 800 and 75 MHz. 
bMeasured in CDCl3 at 900 and 600 MHz.
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Table 7. 1H and 13C NMR data for compounds 25 and 26 isolated from Vitex rotundifolia 
25 26 
Position 
δH δC δH δC 
1 
1.61 (1H, m) 
1.41 (1H, m)  
32.3 
1.66 (1H, m) 
1.61 (1H, m)  
33.9 
2 1.42 (2H, m) 18.4 1.46 (2H, m) 18.3 
3 
1.33 (1H, m) 
1.11 (1H, m) 
41.6 
1.44 (1H, m) 
1.18 (1H, m) 
42.0 
4 - 33.3 - 33.3 
5 1.66 (1H, m) 45.6  1.22 (1H, m) 49.1 
6 1.73 (2H, m) 21.2  1.49 (2H, m) 21.4 
7 
1.63 (1H, m) 
1.29 (1H, m) 
31.5 
1.58 (1H, m) 
0.69 (1H, m) 
32.7 
8 1.73 (1H, m) 30.9 2.40 (1H, m) 31.5  
9 - 81.3 - 82.6 
10 - 39.3 - 39.9 
11 6.57 (1H, d, J=8.8 Hz) 133.8 6.66 (1H, d, J=8.9 Hz) 133.0  
12 6.45 (1H, d, J=8.8 Hz) 133.4 6.44 (1H, d, J=8.9 Hz) 131.8  
13 - 79.3 - 79.5 
14 
1.71 (1H, m) 
1.30 (1H, m) 
34.3 
2.09 (1H, m) 
1.44 (1H, m) 
32.7 
15 1.86 (1H, m) 32.1 1.87 (1H, m) 32.2 
16 0.96 (3H, d, J=6.9 Hz) 17.4 0.96 (3H, d, J=6.9 Hz) 17.2 
17 0.94 (3H, d, J=6.9 Hz) 17.1 0.96 (3H, d, J=6.9 Hz) 17.4 
18 0.86 (3H, s) 33.2 0.88 (3H, s) 33.8 
19 0.82 (3H, s) 22.2 0.87 (3H, s) 21.9  
20 1.05 (3H, s) 17.0 1.13 (3H, s) 14.8  
Measured in CDCl3 at 300 and 75 MHz, respectively. Assignments were aided by 
1H 
gDQCOSY, TOCSY, DEPT, gHMQC, and gHMBC experiments. 
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3.2.10. Spectral Data 
Luteolin (12): a yellow solid; [α]D
20 – 22 (c 0.58, MeOH); EIMS m/z 286 [M]+; 
1H NMR (300 MHz, CD3OD) δ: 7.35 (1H, d, J = 8.3 Hz, H-6'), 7.34 (1H, br s, H-
2'), 6.88 (1H, d, J = 8.3 Hz, H-5'), 6.51 (1H, s, H-3), 6.41 (1H, br s, H-8), 6.18 (1H, 
br s, H-6); 13C NMR (75 MHz, CD3OD) δ: 183.6 (C, C-4), 166.1 (C, C-2), 165.8 
(C, C-7), 163.0 (C, C-5), 159.2 (C, C-9), 150.8 (C, C-4'), 146.8 (C, C-3'), 123.5 (C, 
C-1'), 120.2 (CH, C-6'), 116.6 (CH, C-5'), 114.0 (CH, C-2'), 105.2 (C, C-10), 103.8 
(CH, C-3), 100.0 (CH, C-6), 94.9 (CH, C-8). 
 
Quercetin 3,7-dimethyl ether (13): a pale yellow solid; [α]D
20 – 30 (c 0.03, 
MeOH); EIMS m/z 330 [M]+; 1H NMR (300 MHz, CD3OD) δ: 7.63 (1H, s, H-2'), 
7.54 (1H, d, J = 8.4 Hz, H-6'), 6.89 (1H, d, J = 8.4 Hz, H-5'), 6.58 (1H, s, H-8), 
6.32 (1H, s, H-6), 3.88 (3H, s, 7-OMe), 3.79 (3H, s, 3-OMe); 13C NMR (75 MHz, 
CD3OD) δ: 179.9 (C, C-4), 167.1 (C, C-7), 162.7 (C, C-5), 158.2 (C, C-2), 158.2 
(C, C-9), 149.9 (C, C-4'), 146.3 (C, C-3'), 139.6 (C, C-3), 122.7 (C, C-1'), 122.3 
(CH, C-6'), 116.4 (CH, C-2'), 116.3 (CH, C-5'), 106.6 (C, C-10), 98.8 (C, C-6), 
93.0 (CH, C-8), 60.5 (CH3, 3-OMe), 56.5 (CH3, 7-OMe) 
 
Vitexicarpin (14): a pale yellow solid; [α]D
20 + 10 (c 0.10, MeOH); EIMS m/z 
374 [M]+; 1H NMR (300 MHz, CDCl3) δ: 12.6 (1H, s, 5-OH), 7.67 (1H, dd, J = 8.4, 
2.0 Hz, H-6'), 7.65 (1H, d, J = 2.0 Hz, H-2'), 6.92 (1H, d, J = 8.4 Hz, H-5'), 6.47 
(1H, s, H-8), 5.83 (1H, s, 3'-OH), 3.96 (3H, s, 4'-OMe), 3.93 (3H, s, 7-OMe), 3.90 
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(3H, s, 5-OMe), 3.84 (3H, s, 3-OMe); 13C NMR (75 MHz, CDCl3) δ: 178.7 (C, C-
4), 158.6 (C, C-7), 155.5 (C, C-2), 152.5 (C, C-5), 152.1 (C-9), 148.7 (C, C-4'), 
145.4 (C, C-3'), 138.8 (C, C-3), 132.1 (C, C-6), 123.4 (C, C-1'), 121.4 (CH, C-6'), 
114.2 (CH, C-2'), 110.3 (CH, C-5'), 106.5 (C, C-10), 90.3 (CH, C-8), 60.9 (CH3, 6-
OMe), 60.1 (CH3, 3-OMe), 56.3 (CH3, 7-OMe), 56.0 (CH3, 4'-OMe). 
 
Artemetin (15): a pale yellow solid; EIMS m/z 388 [M]+; 1H NMR (300 MHz, 
CDCl3) δ: 12.6 (1H, s, 5-OH), 7.70 (1H, dd, J = 8.6, 2.0 Hz, H-6'), 7.65 (1H, d, J = 
2.0 Hz, H-5'), 6.97 (1H, d, J = 8.6 Hz, H-2'), 6.49 (1H, s, H-8), 3.97(3H, s, 7-OMe), 
3.96 (3H, s, 4'-OMe), 3.95 (3H, s, 3'-OMe), 3.91 (3H, s, 6-OMe), 3.86 (3H, s, 3-
OMe); 13C NMR (75 MHz, CDCl3) δ: 178.7 (C, C-4), 158.6 (C, C-7), 155.7 (C, C-
2), 152.6 (C, C-9), 152.2 (C-5), 151.3 (C, C-4'), 148.7 (C, C-3'), 138.7 (C, C-3), 
132.2 (C, C-6), 122.8 (C, C-1'), 122.1 (CH, C-6'), 111.2 (CH, C-5'), 110.8 (CH, C-
2'), 106.5 (C, C-10), 90.3 (CH, C-8), 60.9 (CH3, 6-OMe), 60.2 (CH3, 3-OMe), 56.4 
(CH3, 7-OMe), 56.1 (CH3, 4'-OMe), 56.0 (CH3, 3'-OMe). 
 
Vitetrifolin F (16): a colorless syrup; [α]D
20 + 83 (c 0.22, MeOH); EIMS m/z 
304 [M-CH3COOH]
+; 1H NMR (300 MHz, CD3OD) δ: 5.84 (1H, dd, J = 17.4, 10.7 
Hz, H-14), 5.15 (1H, dd, J = 17.4, 1.5 Hz, H-15a), 5.01 (1H, dd, J = 10.7, 1.5 Hz, 
H-15b), 4.80 (2H, dd, J = 12.5, 3.1 Hz, H-7), 4.18 (2H, d, J = 3.1 Hz, H-6), 2.18 
(1H, dq, 12.6, 6.5 Hz, H-8), 2.03 (2H, m, H-1), 1.65 (2H, m, H-2), 1.50 (2H, m, H-
3), 1.48 (2H, m, H-11), 1.22 (2H, m, H-12), 1.21 (3H, s, H-16), 2.09 (3H, s, 7-
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COCH3), 1.15 (3H, s, H-18), 1.05 (3H, s, H-19), 1.05 (3H, s, H-20), 0.94 (3H, d, J 
= 7.0 Hz, H-17); 13C NMR (75 MHz, CD3OD) δ: 172.8 (C, 7-COCH3), 145.9 (CH, 
C-14), 139.6 (C, C-10), 137.1 (C, C-5), 112.3 (CH2, C-15), 76.9 (CH, C-7), 73.8 (C, 
C-13), 65.2 (CH, C-6), 44.1 (C, C-9), 40.8 (CH2, C-3), 40.2 (CH2, C-12), 37.0 (CH, 
C-8), 35.6 (C, C-4), 30.8 (CH2, C-11), 30.0 (CH3 C-18), 29.7 (CH3, C-19), 28.4 
(CH3, C-20), 27.3 (CH3, C-16), 26.8 (CH2, C-1), 21.2 (CH3, 7-COCH3), 20.8 (CH2, 
C-2), 11.6 (CH3, C-17). 
 
Vitetrifolin E (17): a colorless needles, [α]D
20 + 60 (c 0.38, MeOH); EIMS m/z 
304 [M-CH3COOH]
+; 1H NMR (300 MHz, CD3OD) δ: 5.83 (1H, dd, J = 17.3, 10.7 
Hz, H-14), 5.56 (1H, d, J = 3.3 Hz, H-6), 5.15 (1H, dd, J = 17.3, 1.5 Hz, H-15a), 
5.02 (1H, dd, J = 10.7, 1.5 Hz, H-15b), 3.62 (1H, dd, J = 12.4, 3.3 Hz, H-7), 2.02 
(2H, m, H-1), 2.01(3H, s, 6-COCH3), 1.87 (1H, dq, J = 12.4, 6.9 Hz, H-8), 1.62 
(2H, m, H-2), 1.47 (2H, m, H-3), 1.44 (2H, m, H-11), 1.21 (3H, s, H-16), 1.14 (2H, 
m, H-12), 1.08 (3H, s, H-18), 1.04 (3H, s, H-20), 1.01 (3H, d, J = 6.9 Hz, H-17), 
0.94 (3H, s, H-19); 13C NMR (75 MHz, CD3OD) δ: 173.1 (C, 6-COCH3), 145.9 
(CH, C-14), 142.8 (C, C-10), 134.0 (C, C-5), 112.4 (CH2, C-15), 73.8 (C, C-13), 
71.9 (CH, C-6), 70.7 (CH, C-7), 44.0 (C, C-9), 41.0 (CH2, C-3), 40.3 (CH2, C-12), 
40.1 (CH, C-8), 35.5 (C, C-4), 30.9 (CH2, C-11), 29.7 (CH3 C-18), 29.1 (CH3, C-
20), 28.5 (CH3, C-19), 27.2 (CH2, C-1), 27.2 (CH3, C-16), 20.7 (CH2, C-2), 21.8 
(CH3, 6-COCH3), 11.9 (CH3, C-17). 
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Vitetrifolin D (18): a colorless syrup; [α]D
20 + 104 (c 1.28, MeOH); EIMS m/z 
346 [M-CH3COOH]
+, 286 [M-CH3COOH×2]
+; 1H NMR (300 MHz, CD3OD) δ: 
5.84 (1H, dd, J = 17.4, 10.7 Hz, H-14), 5.67 (1H, d, J = 3.3 Hz, H-6), 5.15 (1H, dd, 
J = 17.4, 1.4 Hz, H-15a), 5.02 (1H, dd, J = 10.7, 1.4 Hz, H-15b), 4.85 (1H, dd, J = 
12.7, 3.3 Hz, H-7), 2.08 (1H, m, H-8), 2.06 (2H, m, H-1) 2.01(3H, s, 7-COCH3), 
1.95(3H, s, 6-COCH3), 1.66 (1H, m, H-2a), 1.56 (1H, m, H-2b), 1.50 (2H, m, H-3), 
1.48 (2H, m, H-12), 1.45 (1H, m, H-11a), 1.21 (3H, s, H-16), 1.20 (1H, m, H-11b), 
1.08 (3H, s, H-20), 1.07 (3H, s, H-18), 0.95 (3H, d, J = 6.9 Hz, H-17), 0.91 (3H, s, 
H-19); 13C NMR (75 MHz, CD3OD) δ: 172.6 (C, 7-COCH3), 172.5 (C, 6-COCH3), 
145.8 (CH, C-14), 143.3 (C, C-10), 133.4 (C, C-5), 112.4 (CH2, C-15), 74.4 (CH, 
C-7), 73.7 (C, C-13), 67.5 (CH, C-6), 44.2 (C, C-9), 40.6 (CH2, C-3), 40.2 (CH2, C-
12), 37.8 (CH, C-8), 35.7 (C, C-4), 30.7 (CH2, C-11), 29.6 (CH3 C-18), 28.7 (CH3, 
C-20), 28.5 (CH3, C-19), 27.3 (CH3, C-16), 27.1 (CH2, C-1), 21.4 (CH3, 7-COCH3), 
21.0 (CH3, 6-COCH3), 20.6 (CH2, C-2), 11.5 (CH3, C-17). 
 
Vitexilactone (19): a pale yellow solid; [α]D
20 – 3 (c 0.37, MeOH); EIMS m/z 
318 [M-CH3COOH]
+; NMR data, see Table 5. 
 
(5S*,6R*,8R*,9R*,10S*)-6-acetoxy-9-hydroxy-16-hydroxy-13(14)-labden-
16,15-olide (20): a pale yellow solid; [α]D
20 + 17 (c 0.42, MeOH); HRESIMS 
(negative-ion mode) m/z 393.2286 [M-H]- (calcd. for C22H33O6, 393.2277); NMR 
data, see Table 5. 
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(5S*,6R*,8R*,9R*,10S*)-6-acetoxy-9-hydroxy-15-methoxy-13(14)-labden-
16,15-olide (21): Amorphous white solid; ESIMS (negative-ion mode) m/z 407 [M-
H]-, EIMS m/z 348 [M-CH3COOH
 ]+; 1H NMR (300 MHz, CDCl3) δ: 6.75 (1H, d, 
J = 1.2 Hz, H-14), 5.71 (1H, d, J = 1.2 Hz, H-15), 5.37 (1H, q, J = 2.7 Hz, H-6), 
3.57 (3H, s, 15-OCH3), 2.42 (2H, dd, J = 8.5, 8.0 Hz, H-12), 2.10 (1H, m, H-8), 
2.04 (3H, s, 6-OCOCH3), 1.80 (2H, m, H-11), 1.63 (1H, d, J = 2.7 Hz, H-5), 1.58 
(2H, m, H-7), 1.51 (2H, m, H-2), 1.46 (2H, m, H-1), 1.25 (2H, m, H-3), 1.23 (3H, s, 
H-20), 0.99 (3H, s, H-19), 0.96 (3H, s, H-18), 0.92 (3H, d, J = 6.9 Hz, H-17); 13C 
NMR (75 MHz, CDCl3) δ: 171.4 (C, C-16), 170.3 (CH3 6-OCOCH3), 141.4 (CH, 
C-14), 139.1 (C, C-13), 102.6 (CH, C-15), 77.2 (C, C-9), 70.1 (CH, C-6), 57.2 
(CH3, 15-OCH3), 47.6 (CH, C-5), 43.8 (C, C-10), 43.7 (CH2, C-3), 36.2 (CH2, C-7), 
34.0 (C, C-4), 33.7 (CH2, C-1), 33.7 (CH3 C-18), 32.1 (CH2, C-11), 31.9 (CH, C-8), 
23.8 (CH3, C-19), 22.1 (CH2, C-12), 22.0 (CH3, 6-OCOCH3), 19.1 (CH3, C-20), 
18.7 (CH2, C-2), 16.2 (CH3, C-17). 
 
Aurantiamide (22): amorphous white solid, FABMS m/z 403 [M+H]+; 1H NMR 
(900 MHz, CDCl3) δ: 7.70 (2H, d, J = 11.3 Hz, H-2'/6'), 7.50 (1H, t, J = 11.3 Hz, 
H-4'), 7.42 (2H, t, J = 11.3 Hz, H-3'/5'), 7.31 (2H, t, J = 11.3 Hz, H-3''/5''), 7.26 
(2H, d, J = 11.3 Hz, H-2''/6''), 7.25 (1H, t, J = 11.3 Hz, H-4''), 7.16 (2H, t, J = 11.3 
Hz, H-3'''/5'''), 7.12 (1H, t, J = 11.3 Hz, H-4'''), 7.06 (2H, d, J = 11.3 Hz, H-2'''/6'''), 
4.74 (1H, m, H-5), 4.07 (1H, m, H-2), 3.44 (1H, dd, J = 11.1, 3.5 Hz, H-1a), 3.39 
(1H, dd, J = 11.1, 4.5 Hz, H-1b), 3.26 (1H, dd, J = 13.7, 6.0 Hz, H-8a), 3.02 (1H, 
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dd, J = 13.7, 8.8 Hz, H-8b), 2.77 (1H, dd, J = 13.8, 7.5 Hz, H-9a), 2.67 (1H, dd, J = 
13.8, 7.3 Hz, H-9b); 13C NMR (75 MHz, CDCl3) δ: 170.6 (C, C-4), 167.0 (C, C-7), 
133.5 (C, C-1'), 137.1 (C, C-1'''), 136.7 (C, C-1''), 131.9 (CH, C-4'), 129.3 (CH, C-
2''/6''), 129.0 (CH, C-2'''/6'''), 128.8 (CH, C-3''/5''), 128.6 (CH, C-3'/5'), 128.5 (CH, 
C-3'''/5'''), 127.1 (CH, C-4''), 127.0 (CH, C-2'/6'), 126.5 (CH, C-4'''), 63.6 (CH2, C-
1), 55.3 (CH, C-5), 52.9 (CH, C-2), 38.8 (CH2, C-8), 36.9 (CH2, C-9). 
 
3α-hydroxy pleuroziol (23): a pale yellow solid; [α]D
20 + 15 (c 0.13, MeOH); 
HRFABMS m/z 347.2563 [M+Na]+  (calcd. for C20H36O3Na, 347.2562); NMR data, 
see Table 6. 
 
9αH-manoyl oxide (24): a colorless solid, EIMS m/z 290 [M]+; NMR data, see 
Table 6. 
 
Abieta-11(12)-ene-9α,13α-endoperoxide (25): a colorless solid, [α]D
20 – 37 (c 
0.60, CHCl3); HRESIMS m/z 327.2299 [M+Na]
+ (calcd. for C20H32O2Na, 
327.2300); NMR data, see Table 7. 
 
Abieta-11(12)-ene-9β,13β-endoperoxide (26): a colorless solid, [α]D
20 + 8 (c 
0.27, CHCl3); HRESIMS m/z 327.2292 [M+Na]
+ (calcd. for C20H32O2Na, 
327.2300); NMR data, see Table 7. 
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Abieta-9(11):12(13)-di-α-epoxide (27): a colorless needles, [α]D
20 - 27 (c 0.15, 
CHCl3); HRESIMS m/z 327.2297 [M+Na]
+ (calcd. for C20H32O2Na, 327.2300); 
1H 
NMR (300 MHz, CDCl3) δ: 3.32 (1H, d, J = 3.0 Hz, H-11), 2.99 (1H, d, J = 3.0 Hz, 
H-12), 1.94 (1H, m, H-8), 1.73 (2H, m, H-7), 1.65 (2H, m, H-6), 1.63 (1H, m, H-
14a), 1.45 (1H, m, H-15), 1.38 (2H, m, H-2), 1.32 (1H, m, H-3a), 1.21 (1H, m, H-
14b), 1.20 (1H, m, H-5), 1.12 (1H, m, H-3b), 1.11 (2H, m, H-1), 1.06 (3H, s, H-20), 
0.95 (3H, d, J = 6.8 Hz, H-16), 0.89 (3H, d, J = 6.8 Hz, H-17), 0.86 (3H, s, H-18), 
0.81 (3H, s, H-19); 13C NMR (75 MHz, CDCl3) δ: 68.0 (C, C-9), 58.9 (C, C-13), 
54.7 (CH, C-12), 50.6 (CH, C-5), 49.4 (CH, C-11), 41.4 (CH2, C-3), 37.6 (C, C-10), 
34.5 (CH, C-15), 33.5 (C, C-4), 32.9 (CH3 C-18), 32.8 (CH2, C-7), 32.0 (CH, C-8), 
30.6 (CH2, C-1), 29.1 (CH2, C-14), 21.9 (CH3, C-19), 21.5 (CH2, C-6), 19.6 (CH3, 
C-20), 18.1 (CH3, C-16), 18.0 (CH2, C-2), 17.2 (CH3, C-17). 
 
Ferruginol (28): a colorless needles, [α]D
20 + 22.5 (c 0.13, CHCl3); FABMS m/z 
286 [M]+; 1H NMR (300 MHz, CDCl3) δ: 6.81 (1H, s, H-14), 6.61 (1H, s, H-11), 
3.10 (1H, sept, J = 6.9 Hz, H-15), 2.81 (2H, m, H-7), 2.16 (2H, m, H-1), 1.71 (2H, 
m, H-2), 1.44 (1H, m, H-3a), 1.31 (1H, dd, J = 12.4, 2.3 Hz, H-5), 1.24 (3H, d, J = 
6.9 Hz, H-17), 1.22 (3H, d, J = 6.9 Hz, H-16), 1.19 (1H, m, H-3b), 1.17 (3H, s, H-
20), 1.84 (2H, m, H-6), 0.93 (3H, s, H-18), 0.91 (3H, s, H-19); 13C NMR (75 MHz, 
CDCl3) δ: 150.5 (C, C-12), 148.5 (CH, C-9), 131.2 (C, C-13), 127.2 (C, C-8), 
126.5 (CH, C-14), 110.4 (CH, C-11), 50.4 (CH, C-5), 41.7 (CH2, C-3), 38.9 (CH2, 
C-1), 37.6 (C, C-10), 33.5 (C, C-4), 33.4 (CH3 C-18), 29.8 (CH2, C-7), 26.9 (CH, 
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C-15), 24.9 (CH3, C-20), 22.6 (CH3, C-16), 22.8 (CH3, C-17), 21.7 (CH3, C-19), 
19.4 (CH2, C-6), 19.3 (CH2, C-2). 
 
β-amyrenone (29): a colorless solid, [α]D
20 + 75 (c 0.13, CHCl3); FABMS m/z   
425 [M+H]+; 1H NMR (300 MHz, CDCl3) δ: 5.20 (1H, t, J = 3.6 Hz, H-12), 2.54 
(1H, m, H-2a), 2.36 (1H, m, H-2b), 1.96 (1H, m, H-18), 1.93 (2H, m, H-11), 1.90 
(1H, m, H-1a), 1.66 (1H, m, H-19a), 1.66 (1H, m, H-9), 1.56 (1H, m, H-7a),1.53 
(2H, m, H-6), 1.47 (1H, m, H-22a), 1.39 (1H, m, H-1b), 1.37 (1H, m, H-7b), 1.36 
(1H, m, H-21a), 1.32 (1H, m, H-5), 1.22 (1H, m, H-22b), 1.14 (3H, s, H-27), 1.11 
(1H, m, H-21b), 1.09 (2H, m, H-15), 1.09 (1H, m, H-23), 1.07 (1H, m, H-25), 1.05 
(1H, m, H-24), 1.04 (1H, s, H-19b), 1.02 (3H, s, H-26), 1.00 (2H, m, H-16), 0.87 
(3H, s, H-29), 0.87 (3H, s, H-30), 0.84 (3H, s, H-28); 13C NMR (75 MHz, CDCl3) 
δ: 217.6 (C, C-3), 145.1 (C, C-13), 121.4 (CH, C-12), 55.3 (CH, C-5), 47.5 (C, C-
4), 47.4 (CH C-18), 46.9 (CH, C-9), 46.8 (CH2, C-19), 41.9 (C, C-14), 39.9 (C, C-
8), 39.4 (CH2, C-1), 37.2 (CH2, C-22), 36.7 (C, C-10), 34.8 (CH2, C-21), 34.3 (CH2, 
C-2), 33.4 (CH3, C-29), 32.6 (C, C-17), 32.3 (CH2, C-7), 31.2 (C, C-20), 28.5 (CH3 
C-28), 27.0 (CH2, C-15), 26.6 (CH3, C-23), 26.2 (CH2, C-16), 26.0 (CH3, C-27), 
23.8 (CH2, C-11), 23.8 (CH3, C-30), 21.6 (CH3, C-24), 19.8 (CH2, C-6), 16.8 (CH3, 
C-26), 15.3 (CH3, C-25). 
 
α-amyrenone (30): a colorless solid, [α]D
20 + 94 (c 0.12, CHCl3); ESIMS m/z 
447 [M+Na]+; 1H NMR (300 MHz, CDCl3) δ: 5.13 (1H, t, J = 3.6 Hz, H-12), 2.54 
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(1H, m, H-2a), 2.38 (1H, m, H-2b), 2.01 (1H, m, H-15a), 1.96 (2H, m, H-11), 1.95 
(1H, m, H-19), 1.93 (1H, m, H-16a), 1.89 (1H, m, H-15b), 1.86 (1H, m, H-1a), 1.84 
(1H, m, H-16b), 1.61 (1H, m, H-9), 1.59 (1H, m, H-7a), 1.49 (2H, m, H-6), 1.46 
(1H, m, H-22a), 1.41 (1H, m, H-21a), 1.38 (1H, m, H-1b), 1.38 (1H, m, H-7b), 1.34 
(1H, m, H-5), 1.33 (1H, m, H-20), 1.32 (1H, m, H-18), 1.26 (1H, m, H-21b), 1.26 
(1H, m, H-22b), 1.09 (1H, m, H-23), 1.08 (3H, s, H-27), 1.07 (1H, m, H-25), 1.05 
(1H, m, H-24), 1.05 (3H, s, H-26), 0.91 (3H, s, H-30), 0.81 (3H, s, H-28), 0.78 (3H, 
s, H-29); 13C NMR (75 MHz, CDCl3) δ: 217.6 (C, C-3), 139.6 (C, C-13), 124.1 
(CH, C-12), 59.2 (CH C-18), 55.3 (CH, C-5), 47.5 (C, C-4), 47.0 (CH, C-9), 42.3 
(C, C-14), 41.6 (CH2, C-22), 40.1 (C, C-8), 39.7 (CH, C-19), 39.7 (CH, C-20), 39.5 
(CH2, C-1), 36.7 (C, C-10), 34.3 (CH2, C-2), 33.9 (C, C-17), 32.5 (CH2, C-7), 31.3 
(CH2, C-21), 28.9 (CH3 C-28), 28.2 (CH2, C-15), 26.7 (CH3, C-23), 26.6 (CH2, C-
16), 23.6 (CH2, C-11), 23.3 (CH3, C-27), 21.6 (CH3, C-24), 21.5 (CH3, C-30), 19.8 
(CH2, C-6), 17.6 (CH3, C-29), 16.9 (CH3, C-26), 15.6 (CH3, C-25). 
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3.3. Antiproliferative Effects of Corydalis heterocarpa Secondary 
Metabolites 
3.3.1. Effects of Compounds 1-6 on Cancer Cell Growth 
Antiproliferative effects of the isolated compounds 1-6 against AGS, HT-29, 
HT-1080, MCF-7, and U-937 cancer cells were compared with the control at the 
concentrations of 10, 50, and 100 μM (Fig. 11).  
In comparative analysis, compounds 2, 5, and 6 showed high growth inhibitory 
effects on all five cell lines in a dose-dependent manner (p < 0.05). AGS human 
cancer cells were the most sensitive cell line to the antiproliferative effects of all 
compounds, while U-937 human leukemia cells were the least sensitive. However, 
all compounds still exhibited dose-dependent inhibitory effects, even on 
proliferation of U-937 cells (p < 0.05).  
New compound 6 in particular exerted the highest antiproliferative activity 
among all compounds tested. It was capable of inhibiting the proliferation of the 
AGS, HT-29, HT-1080, MCF-7, and U-937 cells, at rates of 54, 43, 51, 50 and 
17 %, respectively, at a concentration of 100 μM.  
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(a)               (b) 
  




Figure 11. Antiproliferative effects of compounds 1-6 isolated from Corydalis 
heterocarpa in AGS (a), HT-29 (b), HT-1080 (c), MCF-7 (d), and U-937 (e) cells. 
a-f Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
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3.3.2. Apoptosis Induction by Compounds 1-6 in AGS Cancer Cells 
To further characterize whether the inhibitory activity of the compounds 1-6 
against proliferation of cells was related to the induction of apoptosis, activations 
of Bax and Bcl-2 genes were examined by RNA extraction and RT-PCR 
(Antonsson, 2001; Zornig et al., 2002). Since these compounds exhibited the 
highest antiproliferative effect in AGS human gastric cancer cells, their effect on 
expression of Bax and Bcl-2 genes were also examined using AGS human gastric 
adenocarcinoma cells (Fig. 12).  
In the presence of any of the compounds, expression of the anti-apoptotic Bcl-2 
at a concentration of 10 μM decreased, while expression of the pro-apoptotic Bax 
at a concentration of 100 μM increased. The change in rate of Bax expression 
levels was more noticeable with compounds 1, 4, 5, and 6 for the others, at a 
concentration of 100 μM (Fig. 12b). The presence of compound 2 led to significant 
down-regulation of an anti-apoptotic Bcl-2 level (Fig. 12a). Activation of pro-
apoptotic Bax was also observed in the presence of compound 2, but the activation 
level was not high. Among these compounds, 5 most remarkably induced the 
down-regulation of the anti-apoptotic primer Bcl-2 level as well as the up-
regulation of the pro-apoptotic primer Bax level, both in a dose-dependent manner 
(p < 0.05). However, new compound 6 induced simultaneous expression of level of 
both the Bcl-2 and Bax to the highest up-regulation at 100 μM. Members of the 
Bcl-2 subfamily are the most important regulators for characterization of apoptosis 
and can be divided into an anti-apoptotic subfamily including Bcl-2 and a pro-
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apoptotic subfamily including Bax (Miyashita et al., 1994; Roy et al., 1997; 
Deveraux and Reed, 1999). Therefore, the changed rate of Bcl-2 subfamily 
expression levels has been examined to determine apoptotic mechanisms.  
Almost all of the compounds significantly activated p53 and p21 levels in a 
dose-dependent manner (Fig. 13). However, compound 5 up-regulated p53 levels 
even at a concentration of 10 μM but had no effect on p21 levels. Compounds 4 
and 6 caused a dose-dependent activation of both p53 and p21 levels. Compounds 
1 and 2 induced activation of p53 and p21 levels, and p21 levels were activated 
even at 10 μM.  
The correct balance of pro-apoptotic and anti-apoptotic proteins can determine 
whether apoptosis occurs. p53 is a tumor suppressor gene that plays an essential 
role in many types of cell death and apoptosis. p53 can up- and down-regulate the 
pro-apoptotic Bax and anti-apoptotic primer Bcl-2, which can in turn lead to 
disruption of the mitochondrial membrane. Induction of p21 can alter the 
progression of cell cycles, arrest cell growth, and promote the occurrence of 
apoptosis (Gartel and Tyner, 2002). Since p53 is located at upstream of p21, the 
induction of p21 is primarily mediated through a p53-dependent pathway.  
Therefore, these data suggest that part of the antiproliferative activity of these 
compounds is related to up-regulation of p53 and p21, and that apoptosis can be 
induced through a Bax and a Bcl-2 dependent pathway. 
Accordingly, the present work demonstrates that the halophyte Corydalis 
heterocarpa has potent inhibitory effects on proliferation of human cancer cells. 
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The compounds 2, 5 and 6 exhibited higher antiproliferative effects than did the 
other compounds. The antiproliferative effect of 2 was brought about by apoptosis 
induction through the Bax and Bcl-2 dependent pathway and was related to 
significant up-regulation of p53 and p21. Compound 5 suppressed proliferation of 
AGS human adenocarcinoma cells by induction of apoptosis, which was associated 
with a significant decrease in Bcl-2 expression and increase in Bax expression 
through a p53-dependent pathway. In addition, the antiproliferative effect of 6 may 
have been induced by apoptosis through activation of pro-apoptotic Bax expression 
and may also have been related to the significant p53 and p21 expression observed.  
 
 












(a)               (b) 
 
Figure 12. Effects of compounds 1-6 isolated from Corydalis heterocarpa on mRNA 
levels of Bcl-2 (a) and Bax (b) in AGS human gastric cancer cells. Cells were incubated 
with compounds for 24 h, then total RNA was isolated and RT-PCR was performed using 
the indicated primers. The amplified PCR products were run in 1% agarose gel and 
visualized by EtBr staining. GAPDH was used as a housekeeping control gene. 
a-g Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
 













(a)                 (b) 
 
Figure 13. Effects of compounds 1-6 isolated from Corydalis heterocarpa on mRNA 
levels of p53 (a) and p21 (b) in AGS human gastric cancer cells. Cells were incubated with 
compounds for 24 h, then total RNA was isolated and RT-PCR was performed using the 
indicated primers. The amplified PCR products were run in 1% agarose gel and visualized 
by EtBr staining. GAPDH was used as a housekeeping control gene. 
a-g Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
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3.3.3. Effects of Compounds 7-11 on Cancer Cell Growth 
To test whether treatment with compounds 7-11 alters proliferation of cancer 
cells, we incubated the four human cancer cell lines (AGS, HT-29, HT-1080, 
MCF-7 cancer cells) with various concentrations of compounds 7-11 for 24 h and 
assessed cell viability with a MTT assay (Fig. 14).  
Treatment with compounds 7-11 resulted in a dose-dependent cytotoxic response 
on all cancer cell lines and most cancer cells were sensitive to sample treatment. 
Among the compounds tested, compound 10 and 11 had a comparatively high 
antiproliferative effect on human cancer cell lines (p < 0.05). Compound 10 
showed growth inhibitory rates of 44% against HT-1080 cancer cells at a 
concentration of 100 μM. Compound 11 inhibited the proliferation of the AGS, 
HT-1080, and MCF-7 at rates of 43%, 29%, and 39%, respectively, at a 
concentration of 100 μM. AGS human gastric cancer cells were slightly more 
sensitive to treatment with these compounds than were the other cell lines. 
 





(a)               (b) 
  
(c)               (d) 
 
Figure 14. Antiproliferative effects of compounds 7-11 isolated from Corydalis 
heterocarpa in AGS (a), HT-29 (b), HT-1080 (c), and MCF-7 (d) cells. 
a-d Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
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3.3.4. Apoptosis Induction by Compounds 7-11 in AGS Cancer Cells  
To confirm and to further characterize whether the inhibitory activity of the 
compounds 7-11 against proliferation of cells was related to the induction of 
apoptosis, we examined the activations of regulator genes by RT-PCR analysis.  
As shown in Fig. 15, the expression levels of anti-apoptotic Bcl-2 substantially 
decreased, whereas that of pro-apoptotic Bax markedly increased in AGS cells 
treated with the compounds 7-11 compared with control cells. Among them, the 
mRNA expression levels of Bax were more noticeable in compounds 7, 10 and 11 
than others at a concentration of 100 μM. In addition, treatment of compound 7 
most remarkably reduced the level of Bcl-2 to ~30% of control, and compounds 9, 
10 and 11 also similarly down-regulated Bcl-2 levels in a dose-dependent manner 
(p < 0.05).  
The mRNA levels of p53 and p21 were also observed using RT-PCR on the 
AGS cells. The results described in Fig. 16 showed that there was an obviously 
increased expression of p53 and p21 compared with control cells. Particularly, 
compound 11 extremely up-regulated p53 and p21 levels at a concentration of 100 
μM. In case of compound 10, there is no significant difference between the mRNA 
expression levels of p53 and p21 on the control cells, but the expression level of 
p21 at a concentration of 10 μM was higher than other compounds at the same 
concentration.  
To summarize, compounds 10 and 11 exhibited higher antiproliferative effects 
than did the other compounds. These effects may have been induced by apoptosis 
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through activating pro-apoptotic Bax and anti-apoptotic Bcl-2 expressions. In 
addition, the strong antiproliferative effect of compound 11 may be closely related 
to significant up-regulation of p53 and p21.  
 











(a)              (b) 
 
Figure 15. Effects of compounds 7-11 isolated from Corydalis heterocarpa on mRNA 
levels of Bcl-2 (a) and Bax (b) in AGS human gastric cancer cells. Cells were incubated 
with compounds for 24 h, then total RNA was isolated and RT-PCR was performed using 
the indicated primers. The amplified PCR products were run in 1% agarose gel and 
visualized by EtBr staining. GAPDH was used as a housekeeping control gene. 
a-e Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
 











 (a)              (b) 
 
Figure 16. Effects of compounds 7-11 isolated from Corydalis heterocarpa on mRNA 
levels of p53 (a) and p21 (b) in AGS human gastric cancer cells. Cells were incubated with 
compounds for 24 h, then total RNA was isolated and RT-PCR was performed using the 
indicated primers. The amplified PCR products were run in 1% agarose gel and visualized 
by EtBr staining. GAPDH was used as a housekeeping control gene. 
a-e Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
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3.4. Antiproliferative Effects of Vitex rotundifolia Secondary Metabolites 
3.4.1. Effects of Compounds 12, 14 and 15 on Cancer Cell Growth 
Antiproliferative effects of compounds 12, 14 and 15 against AGS, HT-29, HT-
1080 and MCF-7 cancer cells were compared with the control at the concentrations 
of 50, 25, 10, 5 and 1 μM by using a MTT assay (Fig. 17). AGS human cancer cells 
showed the greatest sensitivity to the antiproliferative effect of all compounds in a 
dose-dependent manner (p < 0.05), while MCF-7 human breast cancer cells were 
the least sensitive. In a comparative analysis, compound 14 exhibited the strongest 
antiproliferative effects, at 58% in AGS, 68% in HT-29, 49% in HT-1080 and 32 % 
in MCF-7 cells at a concentration of 50 μM. Compound 14, in particular, greatly 
inhibited the proliferation of the AGS cells, even at a concentration of 1 μM, at rate 
of 43%, which is similar and comparable activity to that of doxorubicin and 
paclitaxel (taxol), a well characterized and widely used anti-tumor agent (Table 8). 
 
Table 8. Antiproliferative effects of paclitaxel (taxol) and doxorubicin 
Cell lines Taxol (IC50) Doxorubicin (IC50) 
AGS 7.61±0.48 0.68±0.02 
HT-29 0.61±0.07 6.38±0.40 
HT1080 33.18±3.48 9.68±2.46 
MCF-7 18.28±1.43 40.83±2.86 
 





Figure 17. Antiproliferative effects of compounds 12, 14 and 15 isolated from Vitex 
rotundifolia in AGS (a), HT-29 (b), HT-1080 (c), and MCF-7 (d) cells. 
a-d Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
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3.4.2. Apoptosis Induction by Compounds 12, 14 and 15 in AGS Cancer Cells 
Changes in gene expression of anti-apoptotic Bcl-2 and pro-apoptotic Bax, by 
treatment of compounds 12, 14 and 15, are shown in Fig. 18. 
Whereas no effects on Bax expression were observed, compounds 12, 14 and 15 
showed a strong stimulating effect on Bcl-2 gene expression. Of the three 
compounds, compound 14 exhibited the strongest down-regulation of Bcl-2 level to 
20% at a concentration of 25 μM.  
As shown in Fig. 19, treatment with compounds 12, 14 and 15 resulted in a 
change in mRNA levels of the p53 tumor suppressor gene and its downstream 
effector p21 in the AGS cells. In the cases of compounds 12 and 15, there was no 
significant effect, but compound 14 remarkably up-regulated p53 and p21 levels at 
a concentration of 25 μM. Therefore, the antiproliferative effect of 14 may have 
been induced by apoptosis through down-regulation of Bcl-2 expression and 
















1 μM  
(a)              (b) 
 
Figure 18. Effects of compounds 12, 14 and 15 isolated from Vitex rotundifolia on mRNA 
levels of Bcl-2 (a) and Bax (b) in AGS human gastric cancer cells. Cells were incubated 
with compounds for 24 h, then total RNA was isolated and RT-PCR was performed using 
the indicated primers. The amplified PCR products were run in 1% agarose gel and 
visualized by EtBr staining. GAPDH was used as a housekeeping control gene. 
a-c Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
 




   







1 μM  
(a)              (b) 
 
Figure 19. Effects of compounds 12, 14 and 15 isolated from Vitex rotundifolia on mRNA 
levels of p53 (a) and p21 (b) in AGS human gastric cancer cells. Cells were incubated with 
compounds for 24 h, then total RNA was isolated and RT-PCR was performed using the 
indicated primers. The amplified PCR products were run in 1% agarose gel and visualized 
by EtBr staining. GAPDH was used as a housekeeping control gene. 
a-c Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
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3.5. Antioxidant Effects of Corydalis heterocarpa Secondary Metabolites 
3.5.1. Cellular Nitric Oxide (NO) Production by Compounds 1-6 
There is a close connection between the murine macrophage cell line (Raw 
264.7) and ROS/RNS-mediated cellular events, because these cells can produce 
high amounts of reactive species after stimulation (Arató et al., 2006). For this 
reason, we examined changes in intracellular NO levels induced by compounds 1-6 
isolated from C. heterocarpa in Raw 264.7 cells that were abundantly producing 
NO due to stimulation with lipopolysaccharide (LPS). Reactive NO can combine 
with O2∙
- to generate peroxynitrite (ONOO-), which can then act as a powerful 
oxidant by the chemical reaction with superoxide (Patel et al., 1999; Reiter et al., 
2002; Virag et al., 2003; Lee et al., 2004; Seo et al., 2004; Chen et al., 2005; Tsao 
et al., 2005; Lee and Seo, 2006). Therefore, NO production is an important step in 
the regulation of NO-mediated diseases. Prior to the analysis of intracellular NO 
levels, the cytotoxic effects of the compounds were examined using a MTT assay, 
in order to determine non-toxic concentrations for the antioxidant activity test (Fig. 
20a). Compared to the control, all compounds (100 and 50 μM) except compounds 
5 and 6 at a concentration of 100 μM showed no significant cytotoxicity (p < 0.05) 
toward Raw 264.7 cells. Therefore, the effects of compounds 1-6 on LPS-induced 
NO production were examined at concentrations of less than 100 μM. The nitrite in 
the cultured medium was detected by the Griess reagent, an indirect method for 
measuring the release of NO (Fig. 20b). In Raw 264.7 cells treated with 1 μg/mL 
LPS for 48hr, the nitrite concentration was 55.9 ± 1.6 μM, which was much higher 
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than that of untreated Raw 264.7 cells (10.3 ± 0.1). In cultures pretreated with 100 
μM of compounds 1-6, the NO production was changed significantly (34.9 ± 1.9, 
16.2 ± 0.2, 35.9 ± 0.5, 47.9 ± 0.6, 63.9 ± 2.2 and 47.3 ± 1.6 μM). Among these, 
compound 2 showed the highest suppression of NO production in a dose-dependent 
manner (100, 50 and 10 μM, respectively, corresponding to a NO production of 
16.2 ± 0.2, 19.9 ± 0.3, 44.5 ± 4.4 μM). The level of NO production at a 
concentration of 100 μM was comparable to that seen in the untreated Raw 264.7 
cells. 
 





(a)              (b) 
 
Figure 20. Effects of compounds 1-6 isolated from Corydalis heterocarpa on cell viability 
as determined by MTT assay (a) and effects of compounds 1-6 on nitric oxide production 
(expressed as nitrite) (b) in LPS-induced Raw 264.7 cells. 
a-e Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
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3.5.2. Scavenging Effects of Compounds 1-6 on Reactive Oxygen Species 
(ROS) 
Chemiluminescence of DCFH-DA has been most widely used to detect several 
ROS and RNS in biological media (Okimoto et al., 2000; Curtin et al., 2002). 
Cellular esterases first hydrolyze 2',7'-dichlorodihydrofluororescein diacetate 
(DCFH-DA) to non-fluorescent 2',7'-dichlorodihydrofluororescein (DCFH2). In 
turn, peroxidases such as cytochrome c and Fe2+ can convert DCFH2 to highly 
fluorescent 2',7'-dichlorofluorescein (DCF) in the presence of H2O2 (Curtin et al., 
2002; Gomes et al., 2005). DCF fluorescence of each compound was described 
only as the result after incubation for 2h. As shown in Fig. 21, DCF fluorescence 
intensity that was increased by H2O2 was significantly decreased, time-dependently, 
in the presence of 10 or 100 μM levels of each compound. Among the compounds 
tested, compounds 1 and 2 generated a more than 50% decrease in intracellular 
ROS levels compared to control, which was treated with an equal volume of PBS 
instead of the compounds. Compound 4 presented the highest ROS-scavenging 
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(b)  compound 1    (c)  compound 2 
  
(d)  compound 3    (e)  compound 4 
  
(f)  compound 5    (g)  compound 6 
 
Figure 21. Effects of compounds 1-6 isolated from Corydalis heterocarpa on intracellular 
ROS levels induced by hydrogen peroxide in Raw 264.7 cells. The cells were incubated 
with different concentrations (100 and 10 μM) of the compounds 1-6 for 120 min (a) and 
with compounds 1-6 for the indicated times (b-g), respectively. DCF fluorescence was 
measured at λexcitation=485 nm and λemission=528 nm. 
a-g Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
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3.5.3. Measurement of Intracellular Glutathione (GSH) Levels in the           
Presence of Compounds 1-6 
Glutathione (γ-Glu-Cys-Gly or GSH), a naturally occurring tripeptide, is a most 
important antioxidant that acts as an ROS scavenger and functions in the regulation 
of the intracellular redox state (Sies, 1999; Curtin et al., 2002; Watson and Jones, 
2003). For this reason, intracellular GSH levels in compound-treated cells were 
measured using a monobromobimane assay. There were no significant differences 
in the GSH levels between cultures pretreated with compounds 1-6 and the control 
group (Fig. 22). However, compound 2 significantly increased GSH level at a 
concentration of 100 μM, yielding an activity 2.8-fold higher than the control 
activity. Thus, compound 2 was highlighted as a potential positive regulator of 
intracellular GSH content and antioxidant enzyme activity in Raw 264.7 cells.  
 





(a)                 (b)  compound 2 
 
Figure 22. Effects of compounds 1-6 isolated from Corydalis heterocarpa on regulation of 
GSH levels in Raw 264.7 cells. The cells were incubated with different concentrations 
(100 and 10 μM) of the compounds 1-6 for 120 min (a) and with compound 2 for the 
indicated times (b). Cellular GSH levels were determined using mBBr as a thiol-staining 
reagent according to the method described in the text measuring mBBr-GSH fluorescence 
intensity at λexcitation=360 nm and λemission =465 nm. 
a-b Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
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3.5.4. Anti-inflammatory Effects of Compounds 1-6 
iNOS and COX-2 genes are closely related to inflammation caused by oxidation 
reactions in cells. Therefore, expression of iNOS and COX-2 genes in activated 
Raw 264.7 cells was further analyzed by means of RNA extraction and RT-PCR 
analysis. As shown in Fig. 23, compounds 1-6 at the concentrations of 100 and 10 
μM decreased mRNA expression levels of iNOS and COX-2 in the presence of 
LPS in a concentration-dependent manner (p < 0.05).  
The rate of change in iNOS expression levels was more noticeable for 
compounds 1-4 than for others at a concentration of 100 μM. In particular, 
compounds 2 and 3 induced strong down-regulation of iNOS levels to 9% and 4% 
of the control level, respectively. The down-regulation of iNOS level by compound 
3 was substantial even at 10 μM (Fig. 23a). On the other hand, in the case of COX-
2, compounds 5 and 6 at 100 μM showed strong inhibition of mRNA expression 
levels (13% and 8%) (Fig. 23b). However, if we consider the cytotoxic effects of 
compounds 5 and 6 mentioned before, we can conclude that compound 2 most 
significantly down-regulated the COX-2 expression levels to 24% and 39% at the 
concentrations of 100 and 10 μM, respectively. Compounds 3 and 4 also decreased 
mRNA expression levels of COX-2 compared with control. It is apparent that all of 
the compounds showed inhibitory effects on the expression of iNOS and COX-2 in 
stimulated Raw 264.7 cells. These data implied that the inhibitory effects of the C. 
heterocarpa compounds on expression of iNOS and COX-2 genes could be partly 
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(a)              (b) 
 
Figure 23. Effects of compounds 1-6 isolated from Corydalis heterocarpa on mRNA 
levels of iNOS (a) and COX-2 (b) in LPS-stimulated Raw 264.7 cells. Cells were 
incubated with compounds for 48 h, then total RNA was isolated and RT-PCR was 
performed using the indicated primers. The amplified PCR products were run in 1% 
agarose gel and visualized by EtBr staining. GAPDH was used as a housekeeping control 
gene. 
a-f Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
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3.6. Antioxidant Effects of Vitex rotundifolia Secondary Metabolites 
3.6.1. Cellular Nitric Oxide (NO) Production by Compounds 16-19 and 23-26 
The cytotoxic effects of compounds 12, 14-19 and 23-26 were examined using 
the MTT assay in order to determine non-toxic concentrations for the antioxidant 
activity test (Fig. 24a). At a concentration of 50 μM, most compounds except 
compounds 14 and 15 showed no significant toxic effects (p < 0.05) on the growth 
of cells. On the basis of these results, compounds 16-19 and 23-26 were used for 
the antioxidant experiments. To measure inhibition of cellular NO production by 
these compounds, Raw 264.7 cells were treated with compounds at concentrations 
of 50 and 10 μM for 1 h, and then stimulated with 1 μg/mL LPS for another 48 h. 
At a concentration of 50 μM, compounds 16-19 exhibited potent inhibitory 
activities on NO production (corresponding to 13.0 ± 0.6, 12.9 ± 1.1, 8.3 ± 0.0, 
10.6 ± 0.1 μM, respectively) compared to the control (20.5 ± 0.1 μM) (Fig. 24b). 
Among the compounds tested, compound 18 exhibited the strongest inhibition in a 
dose-dependent manner.  
 





 (a)              (b) 
 
Figure 24. Effects of compounds 12, 14-19 and 23-26 isolated from Vitex rotundifolia on 
cell viability as determined by MTT assay (a) and effects of compounds 16-19 and 23-26 
on nitric oxide production (expressed as nitrite) (b) in LPS-induced Raw 264.7 cells. 
a-f Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
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3.6.2. Scavenging Effects of Compounds 16-19 and 23-26 on Reactive Oxygen 
Species (ROS) 
ROS-scavenging effects of compounds 16-19 and 23-26 were examined using 
DCFH-DA. DCF fluorescence intensity was found to decrease in dose- and time-
dependent manners in the presence of these compounds, as shown in Fig. 25. Most 
of the compounds were significantly effective at a concentration of 50 μM. In 
particular, compounds 16-18 and 23 showed stronger ROS-scavenging activity 




(b)  compound 16     (c)  compound 17 
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 (d)  compound 18     (e)  compound 19 
  
 (f)  compound 23    (g)  compound 24 
  
 (h)  compound 25     (i)  compound 26 
 
Figure 25. Effects of compounds 16-19 and 23-26 isolated from Vitex rotundifolia on 
intracellular ROS levels induced by hydrogen peroxide in Raw 264.7 cells. The cells were 
incubated with different concentrations (50 and 10 μM) of the compounds 16-19 and 23-26 
for 90 min (a) and with compounds 16-19 and 23-26 for the indicated times (b-i), 
respectively. DCF fluorescence was measured at λexcitation=485 nm and λemission=528 nm. 
a-d Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
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3.6.3. Measurement of Intracellular Glutathione (GSH) Levels in the Presence of 
Compounds 16-19 and 23-26 
Intracellular GSH levels of compounds 16-19 and 23-26 were investigated using 
the monobromobimane assay. At a concentration of 50 μM, GSH levels increased 
in cells treated with compound 19, but the magnitude of increase of GSH level was 
not particularly great. There were no other significant differences in the GSH levels 





Figure 26. Effects of compounds 16-19 and 23-26 isolated from Vitex rotundifolia on 
regulation of GSH levels in Raw 264.7 cells. The cells were incubated with different 
concentrations (100 and 10 μM) of the compounds 16-19 and 23-26 for 90 min. Cellular 
GSH levels were determined using mBBr as a thiol-staining reagent according to the 
method described in the text measuring mBBr-GSH fluorescence intensity at 
λexcitation=360 nm and λemission =465 nm. 
a-c Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
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3.6.4. Anti-inflammatory Effects of Compounds 16-19 and 23-26 
Effects of compounds 16-19 and 23-26 on the expression of iNOS and COX-2 
genes were further examined by RNA extraction and RT-PCR analysis. Upon 
exposure to 1 μg/mL LPS, the expression levels of iNOS and COX-2 mRNA 
increased in comparison with untreated cells (blank) as shown in Fig. 27. 
Pretreatment with compounds 16-19 and 23-26 for 1hr before LPS treatment 
significantly inhibited the expression of iNOS and COX-2 genes (p < 0.05). 
Among these, mRNA expression levels of iNOS were more noticeably decreased 
in response to compounds 17, 19, 23 and 24 at rates of 41%, 33%, 42% and 32%, 
respectively, compared to the others, even at a concentration of 10 μM (Fig. 27a). 
On the other hand, compounds 16, 18, 19 and 24 at a concentration of 50 μM 
showed strong down-regulation of COX-2 expression to 7%, 14%, 20% and 15% 
mRNA levels, respectively (Fig. 27b). These data implied that the inhibitory effects 
of compounds on iNOS and COX-2 genes could be closely related with inhibition 
of nitric oxide and ROS in stimulated macrophages.  
 









100 μM  
10 μM 
(a)         (b) 
 
Figure 27. Effects of compounds 16-19 and 23-26 isolated from Vitex rotundifolia on 
mRNA levels of iNOS (a) and COX-2 (b) in LPS-stimulated Raw 264.7 cells. Cells were 
incubated with compounds for 48 h, then total RNA was isolated and RT-PCR was 
performed using the indicated primers. The amplified PCR products were run in 1% 
agarose gel and visualized by EtBr staining. GAPDH was used as a housekeeping control 
gene. 
a-g Means with the different letters at the same concentration are significantly different (p < 
0.05) by Duncan’s multiple range test. Values are means ± SD (n=3). 
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Conclusions 
In recent years, there has been much interest and research into the influence of 
natural products on several diseases, including aging-related illness, cancer, 
neurodegenerative disease, and cardiovascular disease. Recent epidemiological 
studies have suggested that dietary pattern is commonly associated with the risk of 
chronic diseases (Hu, 2002). This association may be attributed to the presence of 
natural chemo-preventers, such as vitamins, polyphenols, and flavonoids, which 
prevent free radical damage (Park and Pezzuto, 2002; Jung et al., 2004; Lee et al., 
2004; Seo et al., 2004; Lee and Seo, 2006; Stan et al., 2008). Oxygen free radicals, 
or reactive oxygen species (ROS) and reactive nitrogen species (RNS), are products 
of normal cellular metabolism. ROS and RNS are well recognized for playing a 
dual role as both deleterious and beneficial species (Valko et al., 2007). Usually, 
antioxidants defend against the harmful effects of these naturally occurring free 
radicals. However, excessive production of ROS/RNS may lead to oxidative stress, 
which damages normal cellular function and ultimately induces apoptosis or 
necrosis (Nordberg and Arnér, 2001; Gomes et al., 2005). Therefore, oxidative 
stress by ROS/RNS may be the direct or indirect cause of many human diseases 
such as aging, cancer, atherosclerosis, and inflammation.  
For these reasons, interest has considerably increased in searching for naturally 
occurring chemopreventive agents to replace synthetic materials, many of which 
are prohibited due to their carcinogenicity (Sasaki et al., 2002). Therefore, natural 
chemopreventive agents isolated from plants and marine algae represent the most 
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useful and as yet unmined source of material for disease prevention (Park and 
Pezzuto, 2002; Jung et al., 2004; Lee et al., 2004; Seo et al., 2004; Lee and Seo, 
2006; Stan et al., 2008). 
In the present study, Corydalis heterocarpa and Vitex rotundifolia, which are 
salt-tolerant plants and which have been used traditionally as a folk medicine, were 
investigated for their bioactive constituents.  
The investigation of these two salt marsh plants provided eleven compounds, 
including two new compounds, from C. heterocarpa and nineteen compounds, 
including five new compounds, from V. rotundifolia. The chemical structures of 
the two new compounds 4 and 6 from C. heterocarpa were established as (2'S,7'S)-
O-(2-methylbutanoyl)-columbianetin and (2'S)-columbianetin-3'-hydrogen sulfate. 
Five new compounds 20 and 23-26 from V. rotundifolia were determined as 
(5S*,6R*,8R*,9R*,10S*)-6-acetoxy-9-hydroxy-16-hydroxy-13(14)-labden-16,15-
olide, 3α-hydroxy pleuroziol, 9αH-manoyl oxide, abieta-11(12)-ene-9α,13α-
endoperoxide, and abieta-11(12)-ene-9β,13β-endoperoxide. The NMR spectral data 
of the new compounds were completely assigned by a combination of 1D/2D NMR 
experiments including 1H–1H gDQCOSY, TOCSY, DEPT, gHMQC and gHMBC 
correlations.  
The nine known compounds from C. heterocarpa were identified as (2'S)-
columbianetin (1), libanoridin (2), cnidiadin (3), (2'S)-columbianetin-O-β-D-
glucopyranoside (5), isopimpinellin (7), hyunganol Ⅱ (8), cnidimol A (9), 
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cnidimoside A (10) and 2,3-dihydro-4-hydroxy-7-methyl-2-isopropenyl-5H-
furo[3,2g][1] benzopyran-5-one (11).  
The fourteen known compounds from V. rotundifolia were identified as luteolin 
(12), quercetin 3,7-dimethyl ether (13), vitexicarpin (14), artemetin (15), 
vitetrifolin F (16), vitetrifolin E (17), vitetrifolin D (18), vitexilactone (19), 
(5S*,6R*,8R*,9R*,10S*)-6-acetoxy-9-hydroxy-15-methoxy-13(14)-labden-16,15-
olide (21), aurantiamide (22), abieta-9(11):12(13)-di-α-epoxide (27), ferruginol 
(28), β-amyrenone (29) and α-amyrenone (30) by a combination of spectroscopic 
analysis and by comparison with the data reported in the literature.  
Potential inhibitory activity of the isolated compounds against human cancer 
cells was evaluated by MTT assay and mRNA expression of several factors related 
to apoptosis. In comparative analysis, the AGS human cancer cell line was the most 
sensitive to the antiproliferative effect of all of the isolated compounds.  
Among compounds isolated from C. heterocarpa, compounds 2, 5, 6 and 11 
showed strong growth inhibitory effects against human cancer cells in a dose-
dependent manner (p < 0.05). The antiproliferative effect of new compound 6 was 
the highest among all compounds tested. These effects may be caused by 
modulation of apoptosis through the Bax and Bcl-2 dependent pathway and may 
also be related to the significant up-regulation of p53 and p21 seen in response to 
treatment with salt marsh plant secondary metabolites.  
The antiproliferative effects of compounds 12, 14 and 15 isolated from V. 
rotundifolia were compared with the control by MTT assay. Among the tested 
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compounds, 14 exhibited the highest inhibitory activity in the AGS cells. At the 
gene expression levels, it strongly down-regulated Bcl-2 level and up-regulated p53 
and p21 levels. 
The antioxidant activity of the compounds was evaluated by four different 
activity tests, including measurement of intracellular NO, ROS, GSH, and mRNA 
expression of iNOS and COX-2. Compounds 1-6 isolated from C. heterocarpa 
obviously decreased production of NO and ROS, increased production of GSH, and 
inhibited both iNOS and COX-2 expressions under LPS-stimulated condition. 
Compounds 2-4 in particular consistently exhibited higher antioxidant effects 
compared to the other compounds. 
In the cases of compounds 12, 14-19 and 23-26 isolated from V. rotundifolia, 
compounds 16-19 remarkably suppressed NO production while compounds 16-18 
and 23 showed strong ROS-scavenging effects. However, there were no significant 
effects on GSH levels. The expression levels of iNOS and COX-2 were down- 
regulated by compounds 16-19, 23 and 24. On the basis of these above results, 
these compounds may be useful candidates as antioxidant sources for treatment of 
oxidative damage caused by reactive species in macrophage cells. 
Although further studies are needed to confirm these observations, the current 
study suggests that compounds isolated from C. heterocarpa and V. rotundifolia 
may be used to reduce human cancer risk, and that their antiproliferative effects are 
partly related to induction of several genes related to apoptosis, including Bax, Bcl-
2, p53, and p21. In addition, these compounds may be used to retard oxidative 
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destruction by reactive species and thus reduce the risk of many diseases that 
involve oxidative stress, such as aging, cancer, diabetes mellitus, neurological 
disorders, renal disorders, and hypertension.  
Therefore, the two salt marsh plants examined here, C. heterocarpa and V. 
rotundifolia, may be beneficial natural sources of valuable chemopreventive agents 
and may also contribute to the reduction of risks of cancer and other oxidation-
related diseases. 
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나는 8 월   그루 나 입니다 
 에 게 뿌리를  강  나 입니다 
아름 큰   가진 곧  나 입니다 
푸른 늘  향해 가지를 뻗   나 입니다 
강  햇살  듬뿍  푸른 잎  나 입니다 
다가  계 에 단 열매를 맺 ... 
나는 나 입니다. 
 
 여름  나   그루가 를  합니다. 갚진 열매를 맺  해   나아가고자 
합니다. 나 가 열매를 맺는 건 자만  힘이 아니란 것  압니다. 푸른 잎처럼 많  
가르침과 앎  주셨 에 가능  것입니다. 히 뻗  가지처럼 에게 손 내 어  
고마운 벗들이 있었 에 찬 람도 견   있었습니다. 국해양  
해양 경생명과 부라는 든든  이 버 목이 어주었 에 우뚝 자리   있었습니다. 
그리고 엇보다 름진 에 마  뿌리를 도  해주신 가족이 있었 에 가 이 에 
 있는 것입니다. 첫 앓이를   나  주 를 러보며 인사 드립니다.  
구보다 크고  마  부족   끝 지 이끌어 주신  님.. 마지막 지 
히 많  가르침 주신 안종웅, 임 , 희연, 철 생님께 진심  고개 여 감사 
드립니다. 
국해양 는 10 간  집이 습니다. 가족과 같  사랑  만났  많  분들이 
생각납니다. 해양 경생명과 부  든든  님들, 부족  를 믿고 라  착 고 
믿 직  후 들.. 특히 생 신소재연구실 우리 동생들.. 그리고 가 없는 에게 
구보다 큰 가 어주신 공창  사님.. 지칠 마다 많  힘이 었고 큰 사랑 가지고 
갑니다. 고맙습니다.  
내가 살아가는 이 이자 희망인 우리 가족. 큰  항상 믿어주시는 그 마 에 
보답 겠습니다. 그 구보다 존경 고 사랑합니다.  
마지막  내 곁  지 주는 우리 님에게 고맙다는 말  합니다. 
해마다 고 지며 인생  복 겠지만 처 이 지  모습들  잊지 않겠습니다. 
나 가 마지막 열매를 맺는 그날 지 언 나처럼  힘이 어 주십시 .  
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Figure 28. 1H and 13C NMR spectrum of compound 1 isolated from Corydalis heterocarpa 
in CDCl3. 
 







Figure 29. 1H and 13C NMR spectrum of compound 2 isolated from Corydalis heterocarpa 
in CDCl3. 
 







Figure 30. 1H and 13C NMR spectrum of compound 3 isolated from Corydalis heterocarpa 
in CDCl3. 
 







Figure 31. 1H and 13C NMR spectrum of compound 4 isolated from Corydalis heterocarpa 
in CDCl3. 
 








Figure 32. DEPT spectrum of compound 4 isolated from Corydalis heterocarpa in CDCl3. 
 
 





 Figure 33. gDQCOSY and TOCSY spectrum of compound 4 isolated from Corydalis 
heterocarpa in CDCl3. 
 





Figure 34. gHMQC and gHMBC spectrum of compound 4 isolated from Corydalis 
heterocarpa in CDCl3. 
 







Figure 35. 1H and 13C NMR spectrum of compound 5 isolated from Corydalis heterocarpa 
in CD3OD. 
 








Figure 36. 1H, 13C NMR, and DEPT spectrum of compound 6 isolated from Corydalis 
heterocarpa in CD3OD. 
 





 Figure 37. gDQCOSY and TOCSY spectrum of compound 6 isolated from Corydalis 
heterocarpa in CD3OD. 
 





Figure 38. gHMQC and gHMBC spectrum of compound 6 isolated from Corydalis 
heterocarpa in CD3OD. 
 


















Figure 40. 1H and 13C NMR spectrum of compound 8 isolated from Corydalis heterocarpa 
in CD3OD. 
 







Figure 41. 1H and 13C NMR spectrum of compound 9 isolated from Corydalis heterocarpa 
in CD3OD. 
 







Figure 42. 1H and 13C NMR spectrum of compound 10 isolated from Corydalis 
heterocarpa in CD3OD. 
 







Figure 43. 1H and 13C NMR spectrum of compound 11 isolated from Corydalis 
heterocarpa in CD3OD. 
 







Figure 44. 1H and 13C NMR spectrum of compound 12 isolated from Vitex rotundifolia in 
CD3OD. 
 







Figure 45. 1H and 13C NMR spectrum of compound 13 isolated from Vitex rotundifolia in 
CD3OD. 
 





























Figure 48. 1H and 13C NMR spectrum of compound 16 isolated from Vitex rotundifolia in 
CD3OD. 
 







Figure 49. 1H and 13C NMR spectrum of compound 17 isolated from Vitex rotundifolia in 
CD3OD. 
 







Figure 50. 1H and 13C NMR spectrum of compound 18 isolated from Vitex rotundifolia in 
CD3OD. 
 







Figure 51. 1H and 13C NMR spectrum of compound 19 isolated from Vitex rotundifolia in 
CDCl3. 
 







Figure 52. 1H and 13C NMR spectrum of compound 20 isolated from Vitex rotundifolia in 
CDCl3. 
 





 Figure 53. gDQCOSY and TOCSY spectrum of compound 20 isolated from Vitex 
rotundifolia in CDCl3. 
 





Figure 54. gHMQC and gHMBC spectrum of compound 20 isolated from Vitex 
rotundifolia in CDCl3. 
 







Figure 55. 1H and 13C NMR spectrum of compound 21 isolated from Vitex rotundifolia in 
CDCl3. 
 







Figure 56. 1H and 13C NMR spectrum of compound 22 isolated from Vitex rotundifolia in 
CDCl3. 
 







Figure 57. 1H, 13C NMR, and DEPT spectrum of compound 23 isolated from Vitex 
rotundifolia in CD3OD. 
 





Figure 58. gDQCOSY and NOESY spectrum of compound 23 isolated from Vitex 
rotundifolia in CD3OD. 
 





Figure 59. gHMQC and gHMBC spectrum of compound 23 isolated from Vitex 
rotundifolia in CD3OD. 
 







Figure 60. 1H and 13C NMR spectrum of compound 24 isolated from Vitex rotundifolia in 
CDCl3. 
 





Figure 61. DEPT and NOESY spectrum of compound 24 isolated from Vitex rotundifolia 
in CDCl3. 
 





Figure 62. gDQCOSY and TOCSY spectrum of compound 24 isolated from Vitex 
rotundifolia in CDCl3.. 
 





Figure 63. gHMQC and gHMBC spectrum of compound 24 isolated from Vitex 
rotundifolia in CDCl3. 
 







Figure 64. 1H and 13C NMR spectrum of compound 25 isolated from Vitex rotundifolia in 
CDCl3. 
 








Figure 65. DEPT spectrum of compound 25 isolated from Vitex rotundifolia in CDCl3. 
 





Figure 66. gDQCOSY and TOCSY spectrum of compound 25 isolated from Vitex 
rotundifolia in CDCl3. 
 





Figure 67. gHMQC and gHMBC spectrum of compound 25 isolated from Vitex 
rotundifolia in CDCl3. 
 







Figure 68. 1H and 13C NMR spectrum of compound 26 isolated from Vitex rotundifolia in 
CDCl3. 
 








Figure 69. DEPT spectrum of compound 26 isolated from Vitex rotundifolia in CDCl3. 
 





 Figure 70. COSY and TOCSY spectrum of compound 26 isolated from Vitex rotundifolia 
in CDCl3. 
 





Figure 71. gHMQC and gHMBC spectrum of compound 26 isolated from Vitex 
rotundifolia in CDCl3. 
 








































Figure 75. 1H and 13C NMR spectrum of compound 30 isolated from Vitex rotundifolia in 
CDCl3. 
